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 Tendinopathy, or tendon overuse, is one of the most common musculoskeletal 
disorders affecting athletes, laborers, and aging adults. If left untreated, overuse injury 
can progress to partial or full-thickness tears that require surgical intervention. In order to 
develop preventative treatment strategies, it is important to identify the factors that 
initiate tendon damage. The multifactorial etiology of tendon overuse includes 
imbalances in proteases and their endogenous inhibitors that lead to the degradation of 
extracellular matrix (ECM). Cysteine cathepsins and matrix metalloproteinases (MMPs) 
have been implicated in tendon pathogenesis. Though several studies have published the 
effects of a single protease on tendon degradation, this does not provide a complete 
picture of a very dynamic proteolytic network at play in a pathologic environment. Cells 
can produce and secrete many proteases and endogenous inhibitors simultaneously that 
can interact with each other and impact matrix degeneration.  It is not well understood 
how cathepsins and MMPs work cooperatively within and between families to effectively 
degrade tendon ECM. Our lab has identified a temporal regulation of cathepsin K and 
cathepsin L in a rat model of rotator cuff overuse, demonstrating upregulation of 
cathepsins K and L early in the injury time course, while only cathepsin L continued to 
be upregulated during later time points. 
 The objective of this research is to investigate the proteolytic contribution to 
tendon damage. It is hypothesized that cathepsins, especially cathepsin K as the most 
potent collagenase, act in sequence to facilitate ECM degeneration. This study uses a rat 
model of rotator cuff tendinopathy to determine the temporal roles of cathepsins and 
MMPs in supraspinatus tendon overuse injury, as well as a mouse Achilles tendon model 
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to determine the sequential actions of multiple cathepsins on tendon matrix degradation. 
Together, this work determines the biochemical roles of cathepsins and MMPs on tendon 
damage and elucidates mechanisms of protease regulation. Understanding how the 
dynamic proteolytic network contributes to tendon degradation will better inform clinical 





CHAPTER 1. INTRODUCTION  
 Tendinopathy is one of the most common musculoskeletal disorders diagnosed in 
athletes and laborers, and is generally attributed to overuse. Though several intrinsic and 
extrinsic etiological factors have been implicated in tendinopathy, the cascade of events 
that leads to tendon failure is still not well understood. A clinical hallmark of 
tendinopathy is degeneration of extracellular matrix (ECM) components, specifically type 
I collagen. It has been shown that matrix metalloproteinases (MMPs), and more recently, 
cathepsins—a family of cysteine proteases including the most powerful human 
collagenases and elastases—are upregulated in tendinopathic tissues after overuse. 
However, the cooperative effect of proteases on collagen degradation in tendon ECM still 
needs to be investigated. Limited knowledge regarding tendon pathology progression has 
hindered the development of preventative methods and treatment options in early stage 
tendinopathy.  
1.1 Research Objectives and Specific Aims 
 Our long-term goal is to identify key markers of ECM remodeling in tendon 
overuse and exploit their mechanisms of action to help develop potential therapeutic 
strategies. The overall objective of the dissertation is to investigate the proteolytic 
contribution to tendon damage using rodent models and type I collagen gel matrix. The 
central hypothesis is that cathepsins play a sequential role in ECM degeneration and 
progression of tendinopathy. The rationale is that understanding how multiple proteases 
contribute to tendon degeneration will better inform clinical treatment strategies and 
future potential regenerative therapies to prevent tendon failure. The central hypothesis 
will be tested with these specific aims: 
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Aim 1: Determine the temporal roles of proteases in rat supraspinatus tendon 
overuse injury.  Hypothesis: Cathepsin upregulation in the supraspinatus tendon 
insertion tissues will peak at the earliest point of injury in a rat model of rotator cuff 
overuse. It is also hypothesized that both supraspinatus tendon insertion and nearby 
articular cartilage tissues will show evidence of damage and proteolytic upregulation at 
10 weeks of overuse. Skeletally mature Dahl Salt-Resistant rats were obtained and 
subjected to a downhill treadmill model of rotator cuff overuse injury as described 
previously (n=6/group/time point) for 2 or 10 weeks and compared to age-matched 
controls. At each time point, the insertion region of supraspinatus tendons and articular 
cartilage was harvested from control and overuse animals for histological and 
biochemical analysis. Supraspinatus tendons subjected to overuse for 10 weeks exhibited 
significant evidence of damage as quantified by histological scoring. Additionally, 
injured animals after 10 weeks demonstrated significant decrease in cartilage thickness 
and increased cartilage attenuations, suggesting decreased glycosaminoglycan content. 
However, no upregulation of cathepsins or MMPs was quantified at either the 2 or 10 
week time points in supraspinatus tendon or articular cartilage. This suggested that peak 
proteolytic upregulation occurred between the time points, as published previously by our 
lab. These findings are discussed in chapter 3. 
 
Aim 2: Determine the cooperative and interactive effects of cathepsins on collagen 
and tendon matrix degradation.  Hypothesis:  Cathepsin K, the most potent mammalian 
collagenase, initiates collagen degradation by exposing sites further susceptible to 
hydrolysis by mouse cathepsin L. Our rat model of rat rotator cuff tendinopathy in 
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previous work demonstrated an upregulation of cathepsin K and cathepsin L at 4 weeks 
of injury, with only cathepsin L continuing to be upregulated after 8 weeks with evidence 
of tendon damage by the end of the time course. This suggested that the sequential point 
of upregulation for each cathepsin was necessitous to the eventual tissue degeneration. 
We developed collagen gel and mouse tendon ECM models to use as test beds to 
investigate the role of sequential co-incubations of cathepsin K and cathepsin L on matrix 
degradation and enzyme activity. We found increased degradation of matrix primed, or 
pre-incubated, with cathepsin K before co-incubating with cathepsin L when compared to 
matrix that was concurrently co-incubated with cathepsins K and L. These cathepsins 
also exhibited substrate-dependent bi-directional cannibalism not shown in enzyme co-
incubations without substrate. Furthermore, tendon ECM protected active cathepsins K 
and L from autodigestion and sustained activity over time. These data suggested that 
addressing the sequential actions of cathepsins K and L on tendon matrix may be critical 
for effective inhibition strategies. These findings are discussed in chapter 4. 
1.2 Significance and Innovation 
 The complex proteolytic network contributing to tendon degradation is not very 
well understood. Cathepsins and MMPs have separately been implicated in tendon 
pathogenesis, but studies are still needed to investigate how cathepsins and MMPs and 
their inhibitors interact within and between these two families. The overall objective of 
this research is to investigate the proteolytic contribution to tendon damage. We have 
recently discovered a temporally dependent upregulation of cathepsin activity in early 
stage tendinopathy after 4 and 8 weeks of overuse. However, in order to understand how 
this regulation is biochemically relevant in the context of proteolytic actions of multiple 
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proteases, more studies are necessary. Here, we use both in vivo and in vitro models of 
tendon degradation to understand proteolytic mechanisms of ECM degeneration. The 
central hypothesis is that cathepsins and MMPs play a sequential role in ECM 
degeneration and disease progression. 
This research is significant because it aims to gain fundamental understanding of 
the temporal proteolytic regulation between two different proteolytic families and how 
this regulation is biochemically relevant for tendon ECM degradation. The rationale is 
that understanding how these two families of enzymes contribute to tendon degeneration 
will better inform clinical inhibition-based treatment strategies and future potential 
regenerative therapies to prevent full tendon tears. 
Although studies have shown that MMPs are involved in tendinopathic 
development [1–3], as well as upregulated in end stage tendon disorders [2,4], further 
studies are needed to investigate the proteolytic profile of both cathepsins and MMPs in 
tendinopathy. Adding to the data published by this lab, by multiplex gelatin zymography, 
cathepsins and MMP profiles are evaluated at broader time points in the same model of 
rat supraspinatus overuse used previously [5]. This provides information about how these 
proteases are regulated over time in an injury context in a manner not demonstrated in 
other studies.  
Additionally, this research employs two models of matrix degradation that 
incorporate multiple cathepsins incubated in varied sequence and measures the amount of 
matrix degradation and changes in the amount of present cathepsins over time after co-
incubation. Few other studies have examined the biochemical mechanisms of how these 
enzymes synergistically work to degrade insoluble collagen. In total, this work is 
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innovative because it provides mechanistic data on sequential proteolytic degradation of 
tendon that is key to understanding and preventing tendon pathology.   
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CHAPTER 2. LITERATURE REVIEW 
2.1 Cysteine Cathepsins and Extracellular Matrix Degradation 
Proteases are enzymes that catalyze the irreversible hydrolysis reaction on peptide 
bonds. There are more than 500 human proteases, and their proteolytic actions are crucial 
for many homeostatic functions such as immune function and antigen presentation, 
digestion, cell cycle, apoptosis, coagulation, and degradation of other cellular proteins 
[6–8]. They also are involved in many pathological conditions such as cardiovascular 
disease, cancer, osteoporosis, arthritis, and inflammation [6,9,10]. The five major types of 
proteases, as defined by the mechanism of hydrolysis at the active site are serine, metallo, 
aspartic, threonine, and cysteine proteases [6]. 
2.1.1 Cysteine Cathepsins 
2.1.1.1 Cysteine Cathepsin Classification and Localization 
Novel insights from the last 50 years have seen cathepsins emerge as major 
players in cellular regulation, protein turnover, and disease progression [6,7,11–13]. 
Cathepsins have various classifications including serine cathepsins (A and G), aspartic 
cathepsins (D and E), and cysteine cathepsins [11,13,14]. Cysteine cathepsins are the 
largest group of proteases that belong to the papain superfamily in the clan CA, C1a 
family of cysteine proteases [6,8,14]. 11 human cysteine cathepsins have been identified 
by genomic sequencing (cathepsins B, C, F, H, K, L, O, S, V, X, and W) [14].  
Cysteine cathepsins are highly homologous proteases, but particularly, cathepsins 
K, L, S, and V share 60% sequence identity but maintain unique cellular functions 
[6,8,15–17]. Cathepsins B and L are ubiquitously expressed in lysosomes of most human 
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cells [16], while others are not. Cathepsin V has been found in the thymus, testis, brain, 
corneal epithelium, and skin, and cathepsin S is expressed predominantly in antigen 
presenting immune cells [14,16].  Cathepsin K was first identified in osteoclasts and 
ovaries [6,11,12,16,18] but has also been found in synovial fibroblasts and rheumatoid 
arthritic joints [7,9,11,14,17]. Upregulated catK levels were also found in human calcific 
tendons and a rabbit model of flexor tendon injury [19,20]. Genomic sequencing has 
identified all of the cathepsins encoded for humans and mice, however not all human 
cathepsins have homologous mouse equivalents. Cathepsin K is known as the most 
potent mammalian collagenase [21] and is the only cysteine cathepsins that is 
unambiguously implicated in bone resorption in both humans and mice [22]. 
Interestingly, human cathepsin L, human cathepsin V, and mouse cathepsin L while all 
very homologous, sharing 75% sequence identity, all have differing expression and 
functions [8]. Eight evolutionarily related cathepsin sequences were found to be 
expressed exclusively in mouse placenta [8]. Human cathepsin V, not human cathepsin L, 
is the ortholog to mouse cathepsin L [8,15,23], and thus it is imperative to consider their 
functional differences when relating human and mouse pathologies. Human cathepsin V 
is the most powerful mammalian elastase and has been implicated in cancer and 
autoimmune disorders [8,24,25]. Mouse cathepsin L is implicated in diabetes and 
cardiovascular disease [24,26]. 
Cysteine cathepsins were first found in lysosomes, part of the approximately 50 
known lysosomal enzymes. Because of this, cathepsins were thought to be exclusively 
intracellular proteases with general, non-selective proteolytic specificity in the lysosomal 
compartments where they degrade both intracellular and extracellular substrates 
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[7,11,12]. This view dominated the field two decades ago, especially because cathepsins 
are optimally active in an acidic and reducing environment, with the exception of 
cathepsin S which maintains stability and activity at neutral or slightly basic pH 
[11,12,17]. However, cathepsins have since been found outside of the lysosome in 
cytosolic and pericellular spaces as well as associated with the cell membrane, expanding 
the limited view of cathepsin behavior and honing in on their functional specificity [14]. 
For example, cathepsins have been observed in the cytosol during apoptosis [27,28], and 
cathepsins B and L have been found associated with the cell membrane of colorectal 
carcinoma and melanoma cells [14,29,30]. Additionally, cathepsins are secreted in 
extracellular spaces in normal physiological function as with cathepsin K secretion by 
osteoclasts to facilitate bone resorption, but also in pathological conditions, such as the 
synovium of arthritic patients [9,14]. 
2.1.1.2 Regulation of Cathepsin Activity 
Cathepsins are powerful enzymes with broad substrate specificity [11] and due to 
this proteolytic potential in the lysosome and in the extracellular space, they are tightly 
regulated [6,14]. Cathepsins are translated as inactive zymogens in the endoplasmic 
reticulum (ER) with an additional prepropeptide sequence on the N-terminal end that 
blocks the active site. Interestingly, most of the differences between these highly 
homologous enzymes are found in the propeptide sequence. This presents as a way to 
selectively inhibit specific cathepsins when many are present in the same subcellular 
compartment [7]. The prepropeptide sequence serves as a signaling molecule that traffics 
cathepsins through the rough ER to the Golgi, and during this transport the pre-region is 
cleaved. In the Golgi, procathepsins typically undergo post-translational glycosylation 
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tagging with mannose-6-phosphate, as the propeptide acts as an inhibitor to prevent 
unintended autodigestion, or catalysis of a cathepsin by itself [6,11]. This glycosylation 
then targets cathepsins to endolysosomal or lysosomal compartments where the enzyme 
will be activated, or trafficked to the membrane for secretion into the pericellular space.  
This propeptide sequence must be cleaved in order to become a mature and active 
enzyme [8,14,16]. The propeptide can be autocatalytically cleaved under acidic 
conditions, where a cathepsin molecule cleaves its own propeptide sequence, or the 
cathepsin can be activated by other mature cathepsins [11]. 
Additional endogenous regulators of cathepsin activity are the multiple classes of 
cathepsin inhibitors. The largest class of inhibitors is the cystatin superfamily. Cystatins 
are competitive, reversible, tightly binding inhibitors that prevent substrates from being 
cleaved by competitively blocking their entrance into cathepsin active sites. This family 
includes the types 1, 2, and 3 cystatins. Type 1 cystatins, or stefins (cystatins A and B), 
are only intracellular inhibitors. Type 2 cystatins include cystatin C, which is the most 
abundant extracellular cysteine protease inhibitor. Type 3 cystatins, also known as 
kininogens, are multifunctional, multidomain glycoproteins that are predominantly found 
in blood plasma.  Other endogenous inhibitors include serpins that inhibit serine 
proteases, but can also inhibit cathepsins K, L, and S, and herpins that specifically inhibit 
cathepsin L [6,11,13,14,31]. Given that cathepsins have many potential substrates, 
restriction to lysosomal compartments contains active cathepsins, and prevents the 
degradation of unintended substrates. However, when cathepsins escape these 
sequestering compartments or are trafficked to the cellular membrane for secretion, under 
homeostatic and pathological conditions, the presence of endogenous inhibitors keep the 
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proteolytic actions of cysteine cathepsins in check [16]. The dysregulation of cathepsins 
and inhibitor levels are what lead to breakdown of extracellular matrix (ECM) proteins 
[1,2,14,32]. 
2.1.2 Extracellular Matrix Degradation 
 The extracellular matrix is heterogeneous and tissue-specific. ECM fills the 
interstitial space between cells or clusters of cells, and makes up basement membrane that 
provides support for resident cells [33]. It is fundamentally composed of structural 
proteins, proteoglycans and water [14,33], with fibrous proteins and proteoglycans being 
the main classes of macromolecules. Normal remodeling of the ECM occurs in 
homeostatic conditions, but this remodeling can lead to degeneration of the ECM with 
imbalance of proteases and their inhibitors [14]. Many fibrous protein and proteoglycan 
macromolecules are established substrates of cathepsins [11,14,21,30,34,35]. Cathepsins 
can degrade these extracellular matrix components extracellularly as well as 
intracellularly in the lysosomal compartments when matrix proteins are endocytosed by 
cells. [14]. 
 Collagen is the most abundant protein present in mammals, makes up about 30% 
of total protein mass, and serves as the main structural protein of the extracellular matrix 
in many tissues [14]. There are 20 members of the collagen superfamily. A common 
characteristic of collagen is the triple helical structure of the molecules consisting of three 
polypeptide α chains, the amount of which varies between types of collagen. Collagen 
fibrils display a D-periodicity banding pattern of about 67nm and self-assemble into 
staggered microfibrils ranging from 15 to 500nm in diameter, depending on the tissue. 
These fibrils continue to self-assemble with nearby microfibrils in a hierarchical manner 
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to form a tissue unit [36]. Many tissue destructive diseases are characterized by the loss 
of fibrillar collagens, specifically types I and II collagen. Fibrillar collagens can be 
heterotypic, comprised of several collagen types in various tissues [36].  
 Type I collagen represents the vast majority of structural collagens [14]. The type 
I collagen molecule is triple helical and consists of two α1(I) and one α2(I) chains that 
follow repeating Gly-Pro-X, or with hydroxyproline (Hyp), Gly-X-Hyp amino acid 
sequences [14,37–39] (Fig 2.1). A distinguishing feature of cathepsin K is that it is the 
most potent mammalian collagenase, able to cleave at the telopeptide sequences in 
addition to multiple sites within the collagen molecule that other collagenases are not 
able to cleave. Part of this is attributed to the fact that cathepsin K can accept proline 
residues near the scissile region of its active site [14,21]. Although not as potent, 
cathepsins L, V, and S have collagenolytic potential as well [14,21]. Elastin is another 
major fibrillar protein that makes up the ECM. Elastin fibers provide elastic stretch and 
recoiling properties for tissues that experience repeated stretching forces [14,33]. While 
cathepsin V is the most potent mammalian elastase, cathepsins K, L, and S are also able 
to degrade elastin [8,11,23,24].   
 Collagen fibrils and elastin fibrils also form heterogeneous macromolecules with 
proteoglycans that influence collagen and elastin crosslinking, tissue properties, and 
impact proteolytic potential of cathepsins. Proteoglycans are the most abundant 
component of the interstitial matrix.  They are protein-polysaccharide complexes with a 
protein core covalently bound to glycosaminoglycan (GAG) molecules, which are 
polysaccharide repeats. These molecules are highly hydrophilic, drawing water into the 
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ECM, allowing fibers to slide past one another, and providing viscoelastic properties [40–
42]. The types of GAGs present vary by tissue and possess many unique properties.  
 GAGs can have substantial impacts on cysteine cathepsins; rate of autocatalytic 
activation of cathepsins can be accelerated by the presence of GAGs [11], and 
collagenolytic activity of cysteine cathepsins can also be mediated by GAGs. Chondroitin 
sulfate can enhance the collagenolytic activity of cathepsin K, while dermatan, heparan 
sulfate, and heparin can reduce cathepsin activity [25]. Chondroitin sulfate also inhibits 
the elastinolytic activity of cathepsins K and V, showing varied influence on cathepsin 
activity between substrate types [14]. 
2.2 Tendinopathy  
 Tendinopathy is an umbrella term that encompasses many stages of disease 
progression. Tendon injuries may occur due to acute trauma that is coupled with a 
significant inflammatory response or injuries may occur due to chronic degeneration that 
can lead to partial or full-thickness tendon tears [2,43]. The etiology of tendon rupture is 
unclear, but most commonly stems from chronic tendinopathic degeneration [2]. 
Overuse, or early stage tendinopathy due to excessive loading, can cause microtraumas 
with eventual chronic degenerative changes. It still remains controversial as to whether or 
not inflammation plays a role in early stage tendinopathy [44]. Some studies have 
suggested that is unwarranted to have treatment processes for tendinitis, or inflammation 
of the tendon in early stage injury, as most overuse injuries present with no obvious 
inflammation [2,45].  However, other studies analyzing human biopsies have presented 
evidence that there may be a brief inflammatory response in early tendon injury, 
suggesting that inflammation and degeneration may not be mutually exclusive [44].  
Still, the etiology of overuse injury is not well understood, but is considered 
multifactorial [1,2,40,41,46]. Accepted intrinsic factors include 1) excessive mechanical 
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loading that leads to ECM damage and morphological changes of resident tenocytes, 2) 
imbalances in the proteases that degrade ECM components and their endogenous 
inhibitors, and 3) other individual factors such as age, gender, anatomy, and genetic 
disorders [2,43,44,47].  
  Tendinopathy is a common disorder that can occur in any tendon, including 
plantar fasciitis, Achilles tendinopathy, patellar tendinopathy, tennis elbow, golf elbow, 
and rotator cuff tendinopathy [2] Tendinopathy accounts for about 50% of all sports 
injuries, occurring in 30% of all running related injuries, and in 40% of tennis players 
[48–50].  Rotator cuff injuries are the most prevalent cause of shoulder injury, and pain in 
the shoulder is the 3rd most common orthopaedic problem presented to clinicians [51,52]. 
In addition to athletes, rotator cuff injuries commonly affect laborers and aging adults 
[1,53]. It is the most common musculoskeletal problem for people over 65 yrs [40,54]. 
Rotator cuff tendon tears present in about 13% of people in their 50s, 25% of people in 
their 60s, and 50% of people in their 80s [45,46]. Without repair tendon tears can lead to 
damage to surrounding tissues, including muscle atrophy and fatty infiltration, cartilage 
degeneration, and altered joint biomechanics [45,52]. Between 30,000-75,000 rotator cuff 
tendon repair surgeries are performed each year [45]. Depending on patient age and the 
level of degeneration that occurred before surgical intervention, single-tendon and two-
tendon re-tear rates can be between 29 and 94% despite patients having excellent surgical 
outcomes [50,52]. 
The rotator cuff is composed of 4 muscle-tendon complexes: the supraspinatus, 
infraspinatus, subscapularis, and teres minor. These tendons insert onto the humeral head 
and are responsible for transmitting muscle-generated forces to the humeral bone that 
induce movement. The tendons also function to provide stability to the glenohumeral 
joint [2,40,53]. Type I collagen makes up 95% of the total collagen content in tendon, 
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with small amounts of other types of collagen, proteoglycans, and resident tenocytes—
elongated and spindle shaped cells sparsely distributed throughout the tissue that align 
with the collagen [1,2,41]. Tendon is very linearly organized in a hierarchical structure 
that begins with the smallest unit, type I collagen. Collagen molecules organize into 
crimped fibrils, that then self-assembles as fibers, followed by primary, secondary, and 








The proteoglycans bound to the collagen fibrils have a protein core and 
polysaccharide glycosaminoglycan (GAG) side chains. These hydrophilic molecules 
contribute to the viscoelastic mechanical properties of tendon, lubricating the tissue, 
allowing fluid movement [40–42]. The hierarchical structure and crimping nature of the 
Figure 2.1. Schematic of tendon hierarchical structure. 
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collagen-dense tendon is what allows for the support of high forces, as fascicles slide past 
one another in response to mechanical loading [40,43,45,55].  
Cathepsins and MMPs are major players in facilitating ECM remodeling and 
degradation of matrix proteins that lead to degeneration.   Thus, in this study, elucidating 
the role of cathepsins and MMPs as part of the underlying mechanisms contributing to 
early stage tendon injury is important for developing interventions to prevent rupture. 
2.3 Complexity of the Proteolytic Network: Cathepsins and Matrix 
Metalloproteinases 
Proteolysis, the irreversible hydrolysis of covalent peptide bonds in a protein 
sequence, is involved in many cellular processes that dictate normal function and 
remodeling in all tissue systems [6]. Due to their destructive potential, proteases are 
highly regulated by endogenous inhibitors, pH, and activation of zymogens to mature 
forms [6,11,13,16,56,57]. However, imbalances in protease activity and inhibition lead to 
abnormalities, such as altered cell function, apoptosis, and tissue degradation [6,56,57]. 
These proteases and inhibitors are all present intracellularly and can be secreted into the 
extracellular space. As a result, these proteins are able to interact by directly or indirectly 
activating, inhibiting, or enhancing other proteolytic functions, thus contributing to a very 
complex and dynamic proteolytic network [58].  
In addition to cysteine cathepsins, matrix metalloproteinases (MMPs) are a 
proteolytic family whose upregulation, and the downregulation of their endogenous 
inhibitors, have been implicated in numerous disease states, including osteoarthritis and 
osteoporosis, and rotator cuff rupture [3,5,13,40,59–63]. MMPs are a family of 25 zinc-
dependent endopeptidases, most highly expressed in mammals. They are capable of 
 16 
degrading a variety of ECM components and are generally active at a neutral pH 
[3,4,21,64]. Both cathepsins and MMPs are translated and secreted as inactive zymogens 
that must be activated in order to cleave their substrates. Cathepsins (K, L, S, and V) and 
MMPs (1, 2, 8, 9, 13, 14) are the proteases most implicated in the degradation of type I 
collagen (the main component in tendon), but cathepsin K most potently degrades 
collagen. Cathepsins and MMPs, in addition to type I collagen, are known to degrade 
other ECM proteins as well, such as other collagens, proteoglycans, and cell adhesion 
molecules [4,6,21,42,65]. The endogenous inhibitors, cystatins (cathepsins) and tissue 
inhibitors of metalloproteinases (TIMPS), are also highly regulated and can act intra- or 
extracellularly to maintain homeostasis and prevent progression to pathological states 
[3,4,6,13,57,66,67]. 
The activation and inhibition, or crosstalk, between these proteins regulate 
activation, activity, and ECM cleavage even across families and play key roles in 
interfamilial proteolytic function [58]. Cathepsin K has been shown to active and enhance 
MMP-9 activity in human osteoclasts [68]. Our lab has demonstrated protease-on-
protease hydrolysis, or cannibalism, between cathepsins even in the presence of a 
substrate. Less immunodetectable recombinant cathepsin K was observed over a 2hr 
period when it was incubated with elastin, indicating autodigestion, or cleavage of itself. 
Cathepsin S preferentially degraded cathepsin K after 2hrs even when incubated with 
collagen or elastin, and thus, diminished the substrate cleavage potential [69]. 
Furthermore, we have also demonstrated that cathepsin family members can have 
drastically different reactions to broad spectrum inhibition. Treatment of E64, a broad 
spectrum small molecule cathepsin inhibitor, on MDA-MB-231 breast cancer cells  
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increased the amount of active cathepsin S while simultaneously decreasing the amount 
of active cathepsin L after 24 hrs [70]. These studies all illustrate the dynamic complexity 
of the interactions between and within cathepsin and MMP proteolytic families, in 
addition to their inhibitors. Because cells are able to secrete multiple proteases 
simultaneously, the cooperative or antagonistic interactions between them is important 
for understanding how proteolytic upregulation modulates ECM degradation.  
2.4 Analysis of Proteolytic Actions by Cathepsin K and Matrix Metalloproteinases on 
ECM 
Cathepsin K has a unique ability to cleave insoluble collagen as compared to 
MMP-1, -9, or -13. Demineralized bone particles were incubated with cathepsin K, 
MMP-1, -9, and -13, over 96 hrs and degradation was compared to that resulting from 
bacterial collagenase [21]. This study used hydroxyproline spectrometry analysis to 
quantify the amount of collagen solubilized by these enzymes normalized to collagenase. 
Type I collagen digestion and subsequent sequence analysis also revealed cleavage 
differences in MMPs, less collagenolytically potent cathepsins, and cathepsin K [21]. 
MMPs are able to cleave intrahelically through the collagen molecule to form 3/4N-
terminal and 1/4C-terminal fragments that can be further degraded by other enzymes [3], 
and cathepsin L is only able to cleave at the telopeptide ends.  
Cathepsin K, however, is able to cleave not only at the telopeptide ends, but also 
at multiple points within the matrix. Cleave sites were identified 9 and 21 amino acids 
from the N-terminal end of the helical domain in both α1 and α2 chains, 96 and 810 
amino acids from the N-terminal end in the α1 chain, and 99 and 814 amino acids from 
the N-terminal end in the α2 chain. This was further supported by the collagen 
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fragmentation analysis using enzyme-linked immunosorbent assays (ELISA) specific for 
C-terminal (CTx) and N-terminal (NTx) telopeptide fragments, present in the solubilized 
collagen supernatant. The study found that cathepsin K was able to solubilize 
significantly more collagen than any of the MMPs at 24, 48, 72, and 96 hr time points. 
Cathepsin K was also able to generate substantial CTx and NTx fragments while the 
MMPs were not [21]. In a subsequent study published in 2003, it was found that while 
cathepsin K released large amounts of CTx fragments from type I collagen, the MMPs 
released cross-linked carboxyterminal telopeptide of type I collagen (ICTP) fragments 
and no detectable amount of CTx fragments [71,72] (Fig 2.2). These studies demonstrate 
the clearly unique collagen cleavage patterns between catK and collagenolytic MMPs, 
and suggest that the actions of catK may be more important when assessing collagen 




Figure 2.2. Schematic of type I collagen peptides generated by cathepsin K (CTX & 
NTX) and MMPs (ICTP). Adapted from Moskowitz et al. 2007. 
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Another study published work researching the action of recombinant cathepsins 
on proteoglycan and insoluble collagen degradation. Their work suggested, not only that 
cathepsins cleave more effectively in the presence of GAGs [25], but also that collagen-
bound GAGs serve as docking points in the gaps between molecules for cathepsin K to 
bind and form a dimer. The study conjectured that the formation of this complex forced 
the triple helical collagen molecule open and allowed access to the binding points on the 
α-chains and allowed for collagen cleavage by other proteases [42,73]. This would 
suggest that maintaining adequate GAG content within the collagen fibers is necessary to 
facilitate cleavage by cathepsin K. 
The ubiquitous expression of many cathepsins and their potency in degrading 
ECM has made the development of cathepsin deficient models advantageous for studying 
many pathologies [74–76]. The development of cathepsin K deficient mouse models 
allows investigation of its effects in different tissue and organ systems and identify 
potential therapeutic targets for the overexpression of cathepsin K in disease states [6,8]. 
Cathepsin K deficiency ultimately shows reduced capacity for matrix remodeling. These 
mice exhibit osteopetrosis—dense but fragile bone structure—with altered morphology 
and diminished resorptive activity of osteoclasts. The mice also presented with impaired 
vascular repair, severe cognitive abnormalities, lung fibrosis, open fontanels, and other 
bone deformities [74,77]. Interestingly, however, these cathepsin K knockout mice also 
were protected from atherosclerotic and arthritic development. It has also been shown 
that in cathepsin K deficient mice osteoclasts numbers increase and other proteases 
rescue some of the bone resorption lost by the lack of cathepsin K, though to a lesser 
degree of remodeling [71,77]. The cathepsin K deficient animal model provides the 
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unique context to study how the proteolytic network adapts to the loss of catK in the 
network of interactions—specifically, it allows the study of how the accumulation of 
ECM components impacts biochemical and biomechanical cues between matrix and 
cells. Cells may upregulate other proteases or downregulate inhibitors in order to recover 
matrix remodeling capabilities in the absence of the most potent collagenase. 
Furthermore, because cathepsin expression differs between tissues, localized cellular 
changes may reveal the necessity of catK in remodeling of specific tissues. 
2.5 Proteases in Early Stage Rotator Cuff Tendinopathy  
Many animal models, specifically in rats, rabbits, and sheep, have been developed 
to gain fundamental knowledge on the mechanisms of tendon pathogenesis to varying 
degrees of success [46]. In 2000, the Soslowsky lab developed a rat model of rotator cuff 
tendinopathy using a downhill treadmill running regimen to induce tendinopathic damage 
[47]. With rats having a similar coracoacromial arch anatomy to humans, running 
downhill recapitulated human injury as closely as possible, making this model 
advantageous for fundamental research [78]. Using this model, the Soslowsky group was 
able to induce histopathological and mechanical changes similar to the observed 
degeneration from human tissues [47].  
MMPs have been implicated in tendon ECM remodeling [2,4]. Specifically in 
early stage tendinopathy, MMP-2 and MMP-14 have demonstrated increased mRNA and 
active protease levels in a rat overuse model similar to the one developed by the 
Soslowsky lab [79]. Cysteine cathepsins have been implicated in tissue destructive 
diseases such as cancer, osteoarthritis, and osteoporosis [13,59,60]. Our lab has published 
a temporal upregulation of catK and catL in a rat model of rotator cuff overuse adapted 
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from the Soslowsky model. After 4 weeks of injury active catK and catL were 
upregulated, but by 8 weeks, only active catL remained upregulated [5].  The 
upregulation of multiple proteases, in our study as well as others, has motivated further 
investigation of the roles of both cathepsin and MMPs in cleaving tendon ECM 
degradation in order to suggest potential intervention strategies. 
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CHAPTER 3. Supraspinatus Tendon Overuse Results in 
Degenerative Changes to Tendon Insertion Region and Adjacent 
Humeral Cartilage in a Rat Model 
This chapter was adapted from Parks et al. (2016). Supraspinatus tendon overuse results 
in degenerative changes to tendon insertion region and adjacent humeral cartilage in a 
rat model. Journal of Orthopaedic Research, 35(9), 1910-1918. doi: 10.1002/jor.23496 
[80] 
Elements of this chapter were also adapted from Seto et al. (2015). Cathepsins in rotator 
cuff tendinopathy: identification in human chronic tears and temporal induction in a rat 
model. Annals of Biomedical Engineering, 43(9), 2036-2046. doi: 10.1007/s10439-014-
1245-8 [5] 
3.1 Introduction 
Rotator cuff tendon overuse, or tendinopathy, is a common degenerative disorder 
that can result in pain and limited range of motion [1,53]. This injury particularly affects 
athletes and laborers using a repetitive overhead motion, as well as older adults [1,53]. 
Tendinopathy is characterized clinically by changes in tenocyte phenotype, 
disorganization and misalignment of collagen fibers, and decreased mechanical properties 
[1,47]. If left untreated, overuse injuries can predispose tissue to full or partial-thickness 
tears, requiring surgical intervention [2]. Thus, elucidating underlying mechanisms of 
early tendon injury is important to develop new interventions to prevent tendon rupture.  
Though the etiology of overuse is multifactorial, accepted intrinsic factors of 
tendinopathy include both excessive mechanical loading that leads to microtears and 
decreased loading and morphological changes of resident tenocytes, as well as 
imbalances in proteases that degrade extracellular matrix (ECM) components [2,43,78]. 
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Although proteolytic imbalances have been implicated in rotator cuff tendon ECM 
degradation, how proteases cause deterioration in early tendon damage is not well 
understood [45,46]. In previous work, our laboratory demonstrated the clinical 
significance of cathepsins in end stage supraspinatus tendon injury. Zymography on 
debrided human supraspinatus tendon tissues collected during reconstructive surgery 








 Additionally, we showed that after 4 and 8 weeks of rat supraspinatus tendon 
overuse, cysteine proteases cathepsins K and L were upregulated at the tendon insertion 
region (17% of length from the osseotendinous junction) when compared to their age-
Figure 3.1. Cathepsin activity in human chronic rotator cuff tendon tears. 
Zymogram depicts activity of cathepsins K, V, S, and L. Adapted from Seto et al. 2015. 
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matched controls [5]. This finding of cathepsin upregulation only near the insertion 
region motivated the current study to focus on protease activity in tissues near the 
humeral head, notably the tendon insertion and the humeral articular cartilage. We 
investigated tissue degeneration in these areas using a well-established rat model of 
supraspinatus tendon overuse that displays similar bony anatomy to the human rotator 
cuff [5,47,50,78,81,82]. Because our previous experiments focused on tendon damage at 
4 and 8 weeks of overuse, showing cathepsins K and L upregulated at 4 weeks and only 
cathepsin L upregulated at 8 weeks, we have expanded this time course to investigate 
damage at earlier (2 weeks) and later (10 weeks) time points of tendon overuse in order to 
identify the time of greatest tissue damage and peak proteolytic activity. 
Several studies have implicated cathepsin K, the most powerful mammalian 
collagenase [21] in several tissue destructive diseases, including cancer, osteoporosis, and 
osteoarthritis (OA) [59,60,83]. Human cathepsin V is the most potent mammalian 
elastase identified, but also possesses collagenolytic activity and is upregulated in cancer 
and autoimmune disorders [8,24,25].  Its ortholog, murine cathepsin L [15], is 
upregulated in diabetic mice at mRNA and protein expression levels and contributes to 
cardiovascular disease [24,26].  As demonstrated in our previous work [5], cysteine 
cathepsins K and L are active and may result in collagen degradation in tendon overuse 
injury.  In particular, it is known that cathepsin K can cleave collagen at both telopeptide 
ends, and can also cleave intrahelically, making collagen more susceptible to further 
degradation by other proteases [21]. 
Moreover, cathepsins are also capable of cleaving and activating matrix 
metalloproteinases (MMPs) [68]. Thus, examining the proteolytic contributions of these 
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two protease families in tandem could provide valuable mechanistic information about 
ECM degradation in tendon. MMPs are a family of zinc-dependent endopeptidases that 
can degrade and remodel tendon ECM [4,47]. A prior study demonstrated upregulation of 
MMP-1 activity and down regulation of MMP-2 and -3 activity in ruptured human 
supraspinatus tendon [3] while another found upregulation of MMP-2 mRNA and protein 
activity and MMP-14 mRNA in a rat model of overuse [79], similar to the model used in 
the current research. These findings confirm that MMPs are present during injury and 
may be contributing to tendon degeneration in addition to cathepsins.   
Rotator cuff tendons provide stability to the glenohumeral joint, but tears can alter 
joint loading and can induce cartilage degeneration [2,45,84]. Several studies in rats have 
found evidence of osteoarthritic-like changes in cartilage after tendon transection 
(modeling full tendon tears) [81,85,86]. However, it remains unclear how tendon overuse 
injury affects nearby articular cartilage, both in terms of structural damage and 
proteolytic activity. Cathepsin K has been found to be upregulated in osteoarthritic 
cartilage and synovial tissues [59]. Additionally, MMP-2, -9, and -13 have also been 
implicated in human and rat cartilage degeneration [87,88].  Thus, we analyzed articular 
cartilage on the humeral head using safranin-O staining and Equilibrium Partitioning of 
Ionic Contrast agent via micro-computed tomography (EPIC-µCT) [89] after 10 weeks of 
treadmill running to determine if supraspinatus tendon overuse would result in cartilage 
degeneration, as well as examined protease activity in this tissue. 
Overall, the objective of this study was to characterize the level of tissue damage 
and proteolytic activity in supraspinatus tendon insertion tissues after 2 and 10 weeks of 
rat supraspinatus overuse, and also to determine if this model yielded tissue damage in 
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humeral articular cartilage and subchondral bone, or proteolytic upregulation in humeral 
articular cartilage. Based on previous results, as well as their ability to activate MMPs, it 
was hypothesized that the greatest cathepsin upregulation in the supraspinatus tendon 
insertion tissues would occur at the earliest point of overuse. It was also hypothesized 
that both supraspinatus tendon insertion and cartilage tissues would show evidence of 
damage and proteolytic upregulation at 10 weeks of overuse.  
3.2 Methods 
3.2.1 Rat Overuse Model 
All animal procedures in this study were approved by the Georgia Institute of 
Technology Institutional Animal Care and Use Committee. 68 male Dahl Salt-Resistant 
rats (~350 g initial weight, 14-15 weeks initial age) were obtained (Harlan Labs, 
Indianapolis, IN), chosen because they are an inbred strain derived from the outbred 
Sprague-Dawley strain used to develop the injury model and have previously been used 
in work published by our group [5]. Animals were separated into 2 or 10 week control 
and experimental groups. Experimental rats were subjected to a downhill treadmill rotator 
cuff overuse regimen as described previously [47]. 34 animals were trained for 2 weeks, 
running at a 10° decline for 1hr/day for 5days/week increasing speeds up to a final 17 
m/min. Rats were then subjected to overuse for 2 or 10 weeks (n=13/group/time point). 
Age-matched control rats were allowed normal cage activity (n=13/group/time point). At 
each time point, control and overuse animals were sacrificed and supraspinatus tendons 
were harvested from animals designated for tendon histological and biochemical analysis. 
For biochemical analysis, the insertion region of the tendon (first 17% of the length from 
the osseotendinous junction) was isolated prior to analysis. Animals designated for 
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tendon mechanical testing and cartilage biochemical analysis were sacrificed at 10 weeks 
and prepared for further processing. 
3.2.2 Tendon Histology and Scoring 
 For histological evaluation, tendons were embedded in optimum cutting 
temperature (OCT) and frozen in a liquid nitrogen-chilled ethanol slurry. Tendon tissues 
were sectioned into 10 µm longitudinal sections using a cryostat (CryoStar NX70, 
Thermo Fisher Scientific, Waltham, MA). Slides were stained with hematoxylin and 
eosin (H&E) (VWR, Radnor, PA) and the insertion area of each tendon was imaged with 
a Nikon TE2000. H&E stained sections were histologically graded using a semi-
quantitative scale, similar to the Bonar and Movin scales [90]. Within each time point, 
the control and experimental groups were compared and scored in each of the following 
categories: regional variations in cellularity, cell shape, collagen fiber organization, and 
vascularization. A 4-point scoring system was used, where 0 indicated a normal tendon 
appearance and 3 a markedly abnormal appearance. Five graders, blinded from 
experimental group and time point, (TR, LT, JL, MO, JK) scored 4 images from each 
tendon (n=8-9/group/time point). Scores were ranked and analyzed as individual events 
for statistical analysis (see “statistical analysis” section). 
3.2.3 Tendon Mechanical Testing 
 Following a well-established protocol for mechanical testing [47,91], 
supraspinatus tendons (n=10/group/time point) were cleaned of extraneous tissue and the 
humeral bones were mounted into custom-designed acrylic rings using Ortho-Jet BCA 
acrylic resin (Lang Dental, Wheeling, IL) and left in phosphate-buffered saline (PBS) 
overnight to polymerize. Subsequently, tendon width and thickness were measured at the 
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approximate middle point along the length of the tissue using calipers.  Prior to testing, 
the free end of each tendons was clamped with fine grit sandpaper and marked every 
2mm, beginning at the insertion, using India Ink. Tendons were submerged in a 37°C 
PBS bath and preconditioned for 10 cycles. Samples were loaded to failure using a 100N 
load cell at a constant 24µm/s rate on a MTS Mini Bionix II system. Testing was 
captured using a Manta G504B ASG digital Camera (Graftek Imaging, Austin, TX) and 
recorded using LabView. Measurements for determining insertion moduli were taken by 
analyzing displacement between the two lines closest to the insertion region in ImageJ 
(NIH).  
3.2.4 Second Harmonic Generation Imaging 
 Second harmonic generation (SHG) imaging was performed to asses for tendon 
fibrillar structure as previously described [55,92]. For SHG imaging, tendons subjected to 
overuse for 10 weeks and their age-matched controls (n=10/group) were embedded in 
optimum cutting temperature (OCT) and frozen in a liquid nitrogen-chilled ethanol 
slurry. Tendon tissues were sectioned into 30 µm longitudinal sections using a cryostat 
(CryoStar NX70, Thermo Fisher Scientific, Waltham, MA). The insertion area of each 
tendon was imaged with a Zeiss 710 non-linear optics (NLO) confocal microscope using 
an 800 nm excitation wavelength and emission wavelengths between 380 and 420 nm. 
Second harmonic was picked up by photomultiplier tubes to generate images. Images 
were visually analyzed for fiber organization, density, and consistency in crimping across 
the tissue, used to indicate collagen damage in each tendon sample. 
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3.2.5 Cartilage micro-computed tomography (µCT) and Equilibrium Partitioning 
of Ionic Contrast Agent via µCT (EPIC-µCT) 
 For microcomputed tomography, samples (n=8/group/time point) were analyzed 
by µCT and EPIC-µCT based on established techniques [89]. Following sacrifice, 
shoulder joints were scanned using viva CT (Scanco Medical, Brüttisellen, Switzerland) 
at 55kVp, 142µA, and a 200ms integration. Four distinct points along the humeral head 
were chosen for analysis based on 3 subdivided cartilage regions analyzed previously 
[86]. Joint gap thickness was measured at these four points for both control and overuse 
animals. Subsequently, humeral heads from the same shoulders were detached from 
remaining humeral bone and tendons at the insertion region and submerged in a 10% 
solution of Hexabrix 320 ionic contrast agent (Covidien, Dublin, Ireland) at 37°C for 30 
minutes. Humeral heads, oriented based on the location of the removed tissue, were 
scanned in the sagittal plane with the µCT50 (Scanco Medical, Brüttisellen, Switzerland) 
at 45kVp, 200µA, and a 600ms integration time. The Hexabrix attenuation in cartilage at 
equilibration is inversely correlated to glycosaminoglycan (GAG) content, which is lost 
in cartilage degeneration [93]. Following segmentation and reconstruction of the 3D 
images, cartilage thickness, cartilage attenuation, and subchondral bone thickness and 
attenuation were measured at four points along the humeral head for both control and 
overuse animals using µCT50 software.   
3.2.6 Cartilage Histology 
 Scanned humeral heads (n=8/group/time point) were decalcified by submerging 
them in Cal-Ex II (Thermo Fisher Scientific) for 1 week, exchanging solution every other 
day. After complete decalcification was achieved (as verified by a single X-ray scan 
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using the viva CT), humeral heads were rinsed with PBS and embedded in OCT and 
frozen in a slurry of liquid nitrogen-chilled ethanol. The tissue was sectioned to 10µm 
using a cryostat (CryoStat NX70). Slides were stained with 0.5% safranin-O and 0.2% 
fast green stains (Sigma Aldrich, St. Louis, MO) and imaged using a Nikon TE2000 to 
observe sulfated GAG content.  
3.2.7 Multiplex Gelatin Zymography 
 In preparation for zymography, the insertion region of each supraspinatus tendon 
(n=6/group/time point) was isolated, and humeral articular cartilage (n=7/group/time 
point) was carved from the humeral head. Tissues were homogenized in a zymography 
lysis buffer with 0.1mM leupeptin, and the supernatant was collected. Multiplex 
zymography for cathepsins and MMPs was performed as previously described [83,94]. 
Protein concentration in each lysate sample was determined by a micro BCA kit (Thermo 
Fisher Scientific). 11µg of protein from each sample was loaded into 12.5% (cathepsin) 
and 10% (MMP) SDS-polyacrylamide gels embedded with a 0.2% gelatin substrate. 
Using electrophoresis, enzymes separated by molecular weight. Then the gels were 
washed in renaturing buffer to remove the SDS and allow the enzymes to return to their 
active confirmation. Gels were then incubated in pH4 cathepsin assay buffer or pH7.4 
MMP assay buffer for 18hrs at 37°C to allow the proteases to degrade the gelatin. 
Subsequently, gels were stained with Coomassie Blue and destained to reveal white 
bands indicative of active proteases. Gels were then imaged using the ImageQuant LAS 
4000 (GE Healthcare, Little Chalfont, United Kingdom).  
Densitometry analysis was performed on the acquired images using ImageJ. 
Bands in zymography gels comparing control and overuse supraspinatus insertion 
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samples at each time point were normalized to 1ng of recombinant mouse cathepsin L 
(R&D Systems, Minneapolis, MN) and 0.01ng recombinant human MMP-2 (ENZO, 
Farmingdale, NY). Zymography bands from cartilage samples were normalized to the 
control averages for each gel. 
3.2.8 Statistical Analysis 
 The sample sizes were chosen based on power analysis performed on data from 
our previously published work [5]. The power analysis revealed a minimum n=5 for 
tendon and cartilage zymography with α=0.05 and β=0.15. The power analysis showed a 
required n=8 with α=0.05 and β=0.2 for tendon histology and n=5 with α=0.05 and β=0.2 
for tendon mechanical testing. The power analysis revealed a minimum n=8 for cartilage 
µCT imaging with α=0.05 and β=0.05. Histological scoring of tendon insertions was 
evaluated by the non-parametric Mann-Whitney test using Minitab. Data from the Mann-
Whitney analysis was presented as rankings between 0 and 2 based on the frequency of 
each score value. Statistical significance for µCT data was determined by a Student’s t-
test in Minitab. Statistical significance for tendon zymography data was determined using 
a two-way ANOVA between normalized control and overuse data in GraphPad. 
Statistical significance for all other data was determined by a Student’s t-test between 
normalized control and overuse data with a p<0.05 using Microsoft Excel.  
3.3 Results 
3.3.1 Supraspinatus tendon insertion histology 
 Histological staining of 2 week control supraspinatus tendon insertions showed 
minimal damage indicated by aligned collagen fiber structure with elongated, spindle-
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shaped cells (Fig 3.2A). Similarly, the 2 week overuse tissues demonstrated very little 
evidence of damage with minimal fiber disruption and elongated cells (Fig 3.2B). At 10 
weeks, control tissues maintained similar levels of tissue structure with aligned, tightly 
packed fibers and a slight mix of elongated and rounded cells (Fig 3.2C). Only in the 10 
week overuse tissues, however, was there evidence of cellular rounding, collagen fiber 







Figure 3.2. Histological and mechanical assessment of supraspinatus damage at 2 
and 10 weeks of overuse. Collagen fiber thinning, disorganization, and cell rounding 
were seen in the supraspinatus insertion by 10 weeks of overuse. The insertion region 
for 2 week (A) and 10 week control (C) animals are contrasted with the insertion 
region of 2 week (B) and 10 week overuse (D) tendons (n=8-9). Arrows indicated 
rounded tendon cells. Tensile testing of the supraspinatus insertion regions of both 
control and overuse animals showed no significant difference (E) (SD: control: 
±8.7MPa; overuse: ±11.5MPa) (n=10). 
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 Analysis of histological scoring reported decreased variation in cellularity at 2 
weeks in the overuse compared to the controls, while there were no significant 
differences in scores for cell shape, collagen fiber organization, or vascularity at that time 
point. Additionally, only in 10 week overuse animals did tendons receive significantly 
higher scores for cell shape, indicating cell rounding, and in collagen fiber organization, 
indicating a disruption in the collagen fiber arrangement. Neither regional variation of 
cellularity nor vascularization received scores that were statistically different at 10 weeks 
in either experimental group (Table 3.1).  
 
 
Table 3.1. Histological scoring analysis of control and overused supraspinatus 
tendon insertion regions. 
 
 
2 week 10 week 
Category Control Overuse Control Overuse 
Regional Variation 
of Cellularity 
1* 0 0 0 
Cell Shape 0 0 0 1* 
Collagen Fiber 
Organization 
1 1 0 1* 
Vascularization 0 0 0 0 




3.3.2 Supraspinatus tendon insertion mechanical testing 
 No significant difference was found in cross-sectional area between tendons from 
overuse animals (0.66±0.14 mm2) vs. control (0.77±0.16 mm2).  Similarly, analysis of 
mechanical testing results showed no significant differences in the tensile moduli 
between overused (24.5±11.5 MPa) and control (16.3±8.7 MPa) tissues (Fig 3.2E). 
3.3.3 Second harmonic generation imaging of supraspinatus tendon collagen 
structure 
 SHG imaging on supraspinatus insertion regions of rats subjected to overuse for 
10 weeks revealed obvious disturbances in the crimping pattern with indications of fiber 
separation and collagen disorganization in the insertion region (Fig 3.3B). By contrast, 






Figure 3.3. Second harmonic generation imaging of supraspinatus tendon 
insertion region after 10 weeks of overuse. SHG images displaying changes in 
fibrillar structure after 10 weeks of overuse in the insertion region of the supraspinatus 
tendon. The crimping pattern across the tissue in the overuse insertion region appears 





3.3.4 EPIC-µCT & histological analysis of humeral articular cartilage and 
subchondral bone 
 Joint gap distances determined from reconstructed models of the rat glenohumeral 
joint were significantly reduced in running animals (527.3±16.3µm; 264.3±8.9µm; 
291.9±40.7µm; 263.8±29.4µm) in comparison to their age-matched controls 
(616.8±35.9µm; 366.4±32.7µm; 395.1±68.8µm; 336±41.9µm) along the four points on 







Figure 3.4. µCT measurements of glenohumeral joint gap. Joint gap thickness as 
measured by µCT along 4 different points of the glenohumeral joint (A) showed 
decreased joint space in overuse animals as compared to age-matched controls (B) 
(SD: control: ± 35.9, 32.7, 68.8, 41.9µm; overuse: ±16.3, 8.9, 40.7, 29.4µm). * 
denotes significant difference, p-values as stated (n=8). 
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 Measurements from EPIC-µCT scans revealed that cartilage thickness was 
decreased with experimental animals (119.6±6.34µm; 93.2±10.8µm; 74.1±10.4µm; 
56.9±6.43µm) compared to their age-matched controls (195.4±13.4µm; 141.6±7.68µm; 
111.1±11.9µm; 90.1±9.63µm) at each of the four points analyzed (Fig 3.54A,B,C). EPIC-
µCT also revealed decreased GAG content, as indicated by the significant increase in 
contrast dye attenuation (overuse: 2.1±0.18cm-1; control: 1.65±0.14cm-1) (Fig 3.5B,C,F), 
which was confirmed with safranin-O staining of the decalcified humeral heads (Fig 
3.5D,E).  Subchondral bone thickness was higher in overuse animals (216.2±10.9µm) 
compared to control animals (192±17.8µm) (Fig 3.5G). However, there was no difference 
in mineral density of the subchondral bone between the two groups (overuse: 
4.79±0.06cm-1; control: 4.78±0.09cm-1) as demonstrated by quantification of subchondral 






Figure 3.5. EPIC-µCT measurements of humeral articular cartilage and 
subchondral bone. Humeral heads demonstrated a reduced cartilage thickness in 
overuse animals in comparison to their age-matched controls (A) (SD: control: 
±13.4, 7.7, 11.9, 9.6µm; overuse: ±6.3, 10.8, 10.4, 6.4µm). Humeral cartilage also 
displayed decreased GAG content by EPIC-µCT in overuse animals in comparison 
to control (B, C, F) (SD: control: ±0.14cm-1; overuse: ±0.18cm-1) which was 
confirmed with Safranin-O staining of the decalcified humeral head (D, E). While 
subchondral bone thickness was higher in overuse animals as compared to controls 
(G) (SD: control: ±17.8µm; overuse: ±10.9µm), there was no difference in mineral 
attenuation in the subchondral bone (H) (SD: control: ±0.09cm-1; overuse: 
±0.06cm-1). * denotes significant difference, p-values as stated (n=8). 
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3.3.5 Cathepsin and MMP activity in supraspinatus tendon insertion 
 After 2 and 10 weeks of overuse, active cathepsin L was detected in the pH 4 
cathepsin zymograms between 25 and 35kD, while active pro- and mature MMP-2 were 
detected in pH 7.4 MMP zymograms around 68 and 72kD, respectively, in rat 
supraspinatus insertions of both overuse and control animals. Normalized densitometric 
analysis revealed no significant differences in the amounts of either active cathepsin L or 






Figure 3.6. Cathepsin L and MMP-2 activity in supraspinatus tendon insertion. 
No significant differences in active rat cathepsin L or MMP-2 were measured by 
zymography between animals subjected to overuse or age-matched controls of rat 
supraspinatus tendon insertion after 2 weeks (A) (SD: ±9.2,1.5, 6.3, 3.7) or 10 weeks 
(B)(SD: ±0.3, 0.3, 0.8, 0.8) of overuse. Values were normalized to recombinant mouse 
cathepsin L and human MMP-2 in cathepsin and MMP gels, respectively. Zymography 
bands below all plots are representative of the corresponding protease, time, and 
condition (n=6).  
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3.3.6 Cathepsin and MMP activity in humeral articular cartilage 
 Cartilage tissue harvested from 10 week control and overuse rat humeral heads 
assayed by multiplex cathepsin zymography at pH4 exhibited unidentified active bands at 
100 and 75kD (Fig 3.7A). MMP zymography on same tissues exhibited active pro- and 
mature MMP-2 bands at around 72 and 68kD, respectively (Fig 3.7C). Zymograms from 
both proteolytic families exhibited varying amounts of active proteases between 
individual animals, however neither cathepsin nor MMP activity demonstrated any 
significant difference between the control and overuse animals as quantified by 





Figure 3.7. Cathepsin and MMP activity in humeral cartilage. Cathepsins 
appeared active in humeral head cartilage as visualized by zymography, with bands at 
100 and 75 kD (A), but neither band demonstrated significant differences between 
control and overuse cartilage tissues (B) (SD: ±0.7, 0.5). MMPs also appeared active 
by zymography, with bands around 75 and 65 kD, indicative of the pro-form and 
mature form of MMP-2, respectively (C). However, neither band demonstrated 
significance between the control and overuse cartilage tissues (D) (SD: ±0.5, 4.7) 
(n=7). 
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3.4 Discussion  
In addition to tendon degeneration, damage to glenohumeral articular cartilage 
can occur due to rotator cuff tendon injuries [95,96]. Studies have found decreased 
glenoid cartilage thickness, decreased compressive modulus, and diminished histological 
properties after full supraspinatus and infraspinatus rotator cuff tears [85,86]. However, 
to our knowledge, no studies have investigated the effect of overuse injury alone on the 
surrounding tissues. It has been shown that cytokines and proteases are upregulated in the 
synovial fluid after tendon tears, and that these synovial factors are positively correlated 
with the development of early osteoarthritic degeneration [86,97]. This suggests that 
proteases active due to supraspinatus overuse could be contributing to cartilage 
degeneration via the synovial fluid. Given this information coupled with our previous 
observation that damage occurred only at the tendon insertion region, we hypothesized 
concomitant degenerative effects of supraspinatus tendon overuse on tendon and humeral 
articular cartilage at 10 weeks. 
Supporting this hypothesis, results demonstrated structural changes in rat 
supraspinatus tendon insertion and humeral articular cartilage after 10 weeks of 
supraspinatus tendon overuse.  Histological scoring at the 2 week time point indicated 
significant variation in regional cellularity in the control supraspinatus insertions 
compared to the overused tissue (Table 3.1 and Fig 3.2A). Although unexpected, this 
may be a result of the natural level of variation in locations of cells within the tissues of 
both the control and overuse groups at 2 weeks. Furthermore, no other category showed 
any significant differences at this time point, indicating no overall histological evidence 
of pathology over 2 weeks.  At 10 weeks, however, cellular shape and fiber organization, 
two of the main histopathological changes found in injured tendon [1] received 
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significantly greater scores in the overuse samples (Table 3.1 and Fig 3.2D), which is 
reflective of the changes in regional cellularity and shape previously observed after 4 and 
8 weeks of overuse [5]. Taken together, these data suggest that tendon tissue damage 
becomes histologically evident at 4 weeks, continues to degenerate by 8 weeks, and 
persists at 10 weeks, which is consistent with findings from other studies [5,47,90]. 
Mechanical testing demonstrated no difference in insertion tensile modulus (Fig 3.2E) or 
overall tendon modulus (data not shown) between overuse and control animals, indicating 
that not enough damage has occurred to significantly change the overall modulus of the 
entire insertion region. However, the tendon insertion histological scoring and the 
observed humeral cartilage degeneration (discussed below) suggest that damage to the 
joint overall occurs as a result of the overuse injury. 
In addition to quantifying fibrillar and cellular changes with H&E staining and 
scoring, second harmonic generation (SHG) was used to indicate changes in collagen 
fiber density as well as changes in characteristic collagen crimping patterns. Second 
harmonic generation is a non-linear microscopy technique that provides high resolution 
images samples of interest. Collagen is a noncentrosymmetric molecule, and when 
excited with a high intensity laser, the light waves interact, generating a second harmonic 
wave, or light that has twice the energy—twice the frequency and half the wavelength—
of the original beam. Collecting these second harmonic waves and filtering out the others 
allows collagen-specific imaging that provides structural information across the tissue at 
high resolutions without the need of pinholes or exogenous labeling [55,92].  Collagen 
fiber crimping orientation and structural changes from arterial and bone tissue have 
previously been characterized using SHG [55]. Here, evidence of collagen crimp 
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disturbance and decreased collagen fiber organization in the overuse tendons (Fig 3.3) 
provided additional evidence of damage induced by overuse and proteolytic degradation 
without the need for staining.  
To assess damage to articular cartilage in early stages of glenohumeral joint 
injury, we employed contrast-enhanced µCT (EPIC-µCT) [61,85,89]. The decreases 
observed in joint space distance, cartilage thickness, proteoglycan content, and increased 
subchondral bone thickness (Fig 3.4 & Fig 3.5) are all indications of osteoarthritic-like 
changes in the humeral head cartilage [59,89]. The articular cartilage degeneration 
observed may result from altered mechanical loading of the glenohumeral joint and/or 
proteolytic imbalances in the synovial fluid [45,59,85,98,99].  Such results are similar to 
those found in other rat models of traumatic shoulder injury involving tendon transection.  
In one study, cartilage thinning and a significant decrease in elastic modulus was 
observed at several regions across the glenoid in rats 4 weeks after supraspinatus and 
infraspinatus transection compared to their contralateral tissues [85]. Another study used 
a modified Mankin scoring system to quantify damage in glenoid cartilage tissue sections 
12 weeks after either a supraspinatus and infraspinatus tenotomy or a suprascapular nerve 
transection. Significant damage was found as indicated by cellularity, proteoglycan 
content, structure, and tidemark integrity in both injury models when compared to 
controls [86].  
Increased protease activity has been found previously in damaged tendon and 
cartilage tissue. Cathepsin K protein expression was found upregulated in a rabbit model 
of flexor tendon injury [19] and mRNA levels were elevated in human calcific 
tendinopathy [20]. Cathepsin K was also upregulated in human osteoarthritic cartilage 
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[100] and in articular chondrocytes of an osteoarthritic mouse model [67]. MMPs have 
shown increased expression and proteolytic activity, both in human ruptured 
supraspinatus tendons as well as overuse tissues in a rat model after 2 and 4 weeks of 
activity [3,79]. Increased MMP-2, -9, and -13 activity as indicated by zymography and 
fluorescent enzymatic assays was found in human osteoarthritic chondrocytes [87]. In our 
study, in order to understand the proteolytic contribution to tendon damage progression 
observed in this model of overuse injury, we used multiplex gelatin zymography to 
quantify active proteases [83,101]. From cathepsin and MMP zymography on 
supraspinatus insertion tissues we observed no significant upregulation of active forms 
for either of the protease families between control and overuse animals for either 2 or 10 
weeks of injury (Fig 3.6A,B). However, the tendon histology data present indications of 
degeneration by 10 weeks. Our previous findings showed upregulation of cathepsins K 
and L at 4 weeks and cathepsin L at 8 weeks overuse [5]. Along with current data, it 
suggests that the proteolytic activity of both cathepsins and MMPs may be subject to 
multiphasic temporal regulation over the course of overuse injury, and in this particular 
model, are likely upregulated before 10 weeks and induce damage to the ECM as 
observed histologically as early as 4 weeks in our previous study [5].  
The cartilage tissue cathepsin zymography presented high molecular weight 
active bands at 75 and 100kD (Fig 3.7). These bands are thought to be caused by 
cathepsins bound to extracellular matrix, as they were seen in supraspinatus tendon tissue 
and endometriosis lesions [5,102]. These cathepsins are likely bound to insoluble 
collagen and proteoglycans, and may become proteolytically active upon release from 
resident cells [25,73]. These data could provide a mechanism of collagen cleavage in a 
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tendon overuse context for future studies. Although neither cathepsins nor MMPs were 
upregulated in cartilage by 10 weeks of injury, it is possible that, similar to the tendon 
insertion, proteolytic upregulation in the humeral articular cartilage would occur before 
the 10 week point.  Further work is required to investigate the time course of cartilage 
injury due to tendon overuse to better identify when therapeutics might be best 
introduced to reduce damage to both tissues. 
This study included several limitations. The rat was chosen as a model of overuse 
due to coracoacromial arch similarities to the human shoulder. However, it is important 
to note that because rats are quadruped animals, their shoulders are not loaded in the 
same manner as in humans, and therefore do not completely recapitulate the mode of 
clinical overuse. While no known human studies are available that examine cartilage 
changes during tendon overuse, this study may motivate collection of more clinical data 
in this area.  This study was also unable to distinguish whether cartilage or tendon 
degeneration initiates damage to other tissue in the joint, or if these occur concurrently.   
In summary, this work has exhibited degeneration in multiple tissues adjacent to 
the humeral head as a result of an overuse protocol, as quantified by histological scoring 
of rat supraspinatus tendon tissues as well as cartilage thickness and dye attenuation as 
measured by EPIC-µCT. In tendon tissues, active cathepsin L and MMP-2 were not 
upregulated in overused tissues compared to their age-matched controls. Similarly, after 
10 weeks of tendon overuse, humeral articular cartilage also showed no significant 
difference between control and overuse tissues in terms of proteolytic activity. This work 
suggests a necessity to treat both the tendon and nearby cartilage to slow or reverse tissue 
damage during glenohumeral overuse injuries. Taken together with our previous data that 
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indicates upregulation in cathepsins in tendon overuse injury, these results also highlight 
the importance of elucidating temporal regulation of proteolytic activity to best determine 
timing of any future therapeutic strategies employing protease inhibitors.        
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CHAPTER 4. Sequence Matters: Priming Type I Collagen-Rich 
Extracellular Matrix with Cathepsin K Before Incubating with 
Mouse Cathepsin L Results in Enhanced Degradation 
This chapter was adapted from Parks et al. (2018). Sequence Matters: Priming Type I 
Collagen-Rich Extracellular Matrix with Cathepsin K Before Incubating with Mouse 
Cathepsin L Results in Enhanced Degradation. In preparation. 
4.1 Introduction 
Tendinopathy, also known as tendon overuse, is the most common tendon injury 
and can cause significant pain and limited range of motion. One of the clinical hallmarks 
of tendinopathy is the degeneration of tendon extracellular matrix (ECM) [1,46,52]. If 
left untreated, early tendon injury can progress to full tendon rupture, concomitant 
degeneration of other joint tissues, and abnormal joint mechanics [1,2,45,50,80,96]. 
Multiple etiological factors of tendinopathy contribute to pathological tendon 
degeneration, including mechanical overload that can cause microtrauma, and 
particularly dysregulated expression of proteases and their endogenous inhibitors in 
resident tenocytes [1,2,14,32]. Type I collagen accounts for 95% of the total collagen 
content in tendon with small amounts of types III and V [1,2,103–105]. Other tendon 
components include approximately 2% elastin and 1-2% proteoglycans, largely decorin 
and byglycan [1,2,45,105,106].  
Collagenolytic proteases are important to tendon matrix homeostasis by 
facilitating normal collagen turnover and ECM remodeling during wound healing 
[2,3,66]. However, upregulated collagenases, namely cysteine cathepsins and matrix 
metalloproteinases (MMP), have been reported in tendinopathic progression 
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[2,3,5,32,40,61,63,66,79]. Cysteine cathepsins are a family of proteases, implicated in 
numerous tissue destructive diseases, including orthopaedic tissues [6,7,11–13,21]. CatK 
is the most potent mammalian collagenase, able to cleave the collagen molecule at 
multiple sites within the triple helix and at the telopeptide ends [21]. CatK is primarily 
responsible for normal osteoclastic bone resorption in both humans and mice [21,22], 
however, elevated catK mRNA levels were also measured in human calcified tendon 
tissues [20]. Increased catK expression was also found in a rabbit model of flexor tendon 
injury [19]. Human cathepsin V (catV) is the most potent mammalian elastase with some 
collagenolytic activity, and is orthologous to murine cathepsin L (catL). CatL is 
ubiquitously expressed in mice and was found to be upregulated in diabetes and 
cardiovascular diseases [8,23–25].  
We have recently demonstrated upregulated active cathepsins in a downhill 
treadmill rat model of early stage rotator cuff tendon injury [5,80]. In our rat model, we 
observed an upregulation of both catK and catL after 4 weeks of overuse, and catL 
remained upregulated after 8 weeks of  overuse, with evidence of tissue damage to 
tendon and articular cartilage by 10 weeks [5,80]. These data showed that the resident 
tendon cells produced and secreted multiple cathepsins at different stages of the overuse 
injury resulting in degradation of the tendon ECM, suggesting that cathepsin upregulation 
was important to the eventual tissue degeneration. Thus, elucidating how catK and catL 
work together to degrade tendon is imperative for the development of appropriate and 
effective therapeutics.  
Some studies have investigated how multiple proteases, within and between 
families, work synergistically to degrade a shared substrate. One study showed that 
 48 
cathepsins L, B, S, and F were only able to fully degrade type I collagen fragments in the 
presence of chondroitin-4 sulfate after first being cleaved by MMP-1 [25]. Increased 
degradation of type I collagen fibers with age-related modifications by catK have also 
reported after the fibers were initial cleaved by collagenolytic MMP-1, MMP-8, and 
MMP-13 [107].  Additionally, concurrent and sequential combinations of cathepsins B, 
L, D and calpain demonstrated varied synergistic capacities to degrade and disassemble 
myofibrillar protein of grass carp, suggesting that multiple cysteine proteases in sequence 
may be driving increased rate of tissue degradation [108]. Previously, it has been 
published that catK is subject to autodigestion, or self-cleavage over time [69]. 
Additionally, we have published that cathepsins can hydrolyze other cathepsins, even in 
the presence of a substrate, a phenomenon we have termed cathepsin cannibalism 
[69,109]. These studies suggest that cooperative substrate cleavage, autodigestion, and 
cannibalism between multiple proteolytic species can dictate the amount of active 
proteases in a system as well as the amount of tissue degradation. However, it is still 
unclear how multiple simultaneously present cathepsins impact tendon ECM degradation, 
particularly of type I collagen. 
In this study we employed polymerized collagen gel and homogenized tendon 
ECM incubation models as test beds to investigate how catK and catL act in concert to 
degrade these collagen matrix substrates. These experimental systems were used to test 
the hypothesis that catK initiates substrate degradation, exposing sites susceptible to 
further hydrolysis by catL, and thus, pre-incubating matrix substrate with catK before 
introducing catL would prime the collagen molecules, resulting in greater hydrolysis than 
when concurrent co-incubated with catK and catL.  
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4.2 Methods 
4.2.1 Collagen Gels Preparation 
For collagen gel preparation, soluble rat tail type I collagen (Gibco/Thermo, 
Waltham, MA) at 3mg/mL was combined with deionized water, 10X phosphate-buffered 
saline (PBS), and 1N NaOH to obtain a 2mg/mL solution at pH between 6.5 and 7.5. 
50µL collagen gels were polymerized in 1.5mL microcentrifuge tubes. After 
polymerization, gels were washed in a 0.1M sodium phosphate buffer with 2mM 
dithiothreitol (DTT) and 1mM ethylenediaminetetraacetic acid (EDTA) at pH6, hereafter 
referred to as pH6 assay buffer.   
4.2.2 Mouse Achilles Tendon Isolation and ECM preparation 
All animal procedures were approved by the Georgia Institute of Technology 
Institutional Animal Care and Use Committee. Mice deficient in apolipoprotein E (ApoE-
/-) were obtained from Jackson Laboratory (Bar Harbor, ME). These animals were chosen 
because they share the background genotype with additional cathepsin deficient animal 
models for use in future studies. ApoE-/- mice were bred and progeny were raised to 2-4 
months of age and then sacrificed. The left and right Achilles tendons were extracted 
from 37 ApoE-/- mice. Each tendon was separated from the gastrocnemius muscle tissue 
and bluntly cut at the calcaneous insertion point. Tendons were then frozen in PBS at -
20°C until needed for homogenization.  
For tendon ECM preparation, tendons from ApoE-/- mice were homogenized in 
zymography lysis buffer with 0.1mM leupeptin in tissue grinding microcentrifuge tubes 
with resin (Sigma-Aldrich, St. Louis, MO) and then centrifuged to remove the soluble 
tendon tissue lysate. The remaining homogenized tendon ECM was pooled, well mixed, 
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and redistributed into microcentrifuge tubes for each cathepsin incubation, including no-
cathepsin controls. The insoluble tendon ECM was washed in pH6 assay buffer, and then 
the buffer was aspirated in preparation for incubations.  
In preparation for the time course experiment, pooled insoluble tendon ECM was 
incubated in pH6 assay buffer for 8hrs at 37°C with slight agitation. Tendon samples 
were centrifuged and the soluble releasate (pH6 assay buffer with non-enzymatically 
released soluble tendon ECM fragments) was collected and pooled for subsequent 
cathepsin incubations.  
4.2.3 Cathepsin incubations with collagen gels and tendon ECM  
For all cathepsin incubations, recombinant human cathepsin K (ENZO, 
Farmingdale, NY) and recombinant mouse cathepsin L (Novoprotein, Summit, NJ,) were 
incubated at a 0.2µM concentration in pH6 assay buffer with collagen gels or tendon 
ECM, in addition to a no-cathepsin control with only pH6 assay buffer added to collagen 
gels or tendon ECM. All incubations were conducted at 37°C with slight agitation for 8 
hrs total. Recombinant human cathepsin K (catK) and mouse cathepsin L (catL) were 
incubated individually with collagen gels or tendon ECM, with the same start point or 
concurrently, or in sequential combinations, where the primary cathepsin was pre-
incubated alone for 4hrs and the secondary cathepsin was added at the 4hr mark 
continuing to 8hrs. For the sequential condition with collagen gels, gels were primed with 








The sequential groups for tendon ECM were as follows: tendon ECM was 1) 
primed with catK and then incubated with catL, 2) primed with catL and then incubated 
with catK, 3) primed with catK and then incubated with additional, fresh catK, and 4) 
primed with catL and then incubated with additional, fresh catL. After the incubation 
period, to stop the reaction, leupeptin was added as a weak cathepsin inhibitor to each 
sample to a final concentration of 0.1mM. All samples were centrifuged at 13,200rpm for 
15 min at 25°C. The supernatant was collected, referred to as the soluble fraction, and 
contained released collagen fragments and free, unbound cathepsins. The pellet fraction, 
containing the remaining insoluble collagen or tendon ECM along with any cathepsins 
associated, or bound to the matrix, was reconstituted with zymography lysis buffer with 
0.1mM leupeptin.  
Figure 4.1. Schematic of catK and catL individual, concurrent, and sequential 
incubation conditions with type I collagen gels. 
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In the time course incubation experiments, pooled soluble tendon ECM releasate 
was 1) incubated with concurrent catK and catL, 2) primed with catK for 4hrs before 
introducing catL, and 3) primed with catL for 4hrs before introducing catK. Each of these 
reactions was stopped after 4, 6, or 8hrs of incubation. In the two sequential conditions, 
for the 4hr time point, the reactions were stopped without the addition of the secondary 
cathepsin. At the end of each time point, leupeptin was added to each reaction to a final 
concentration of 0.1mM, and all samples were frozen at -80°C. 
4.2.4 SDS-PAGE and Western Blotting 
In preparation for electrophoresis, each soluble fraction and remaining pellet 
fraction were prepared with 5X reducing loading dye for SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and Western blotting. For Western blot, equal volumes of 
each sample were loaded into 12.5% polyacrylamide gels and separated by molecular 
weight. After separation, samples from each gel were transferred onto a nitrocellulose 
membrane. The remaining gels were stained with Coomassie Blue and destained, 
revealing bands indicative of type I collagen α1 and α2 chains, and β-chains, indicating 
an α-chain dimer [18,25,110–113]. Membranes were blocked with Odyssey blocking 
buffer, then washed in primary rabbit anti-human catK polyclonal antibody (Protein 
Tech, Rosemont, IL) overnight. The membranes were then incubated with anti-rabbit 
secondary antibody (LI-COR, Lincoln, NE) and imaged. Afterwards, membranes were 
stripped and re-probed with goat anti-mouse catL monoclonal antibody (R&D Systems, 
Minneapolis, MN) and appropriate anti-goat secondary antibody (LI-COR, Lincoln, NE) 
and imaged. All membranes were imaged using LI-COR Odyssey CLx (LI-COR, 
Lincoln, NE).  
 53 
4.2.5 Multiplex cathepsin zymography 
In preparation for electrophoresis, each soluble fraction and remaining pellet 
fraction were prepared with a 5X non-reducing loading dye for zymography. 
Zymography was performed as previously described [83,94]. Briefly, equal volumes of 
each sample were loaded into 12.5% SDS-PAGE gels embedded with a 0.2% gelatin 
substrate. After electrophoresis, gels were washed in renaturing buffer to allow the 
cathepsins to refold into their native, active confirmations. Then gels were incubated in 
pH4 sodium acetate or pH6 sodium phosphate buffers with 2mM DTT and 1mM EDTA 
for 18hrs at 37°C to allow the cathepsins to degrade the embedded gelatin substrate. After 
incubation, the gels were stained with Coomassie Blue and destained to reveal cleared 
white bands where active cathepsins degraded the substrate.  
All gels were imaged with the ImageQuant LAS 4000 (GE Healthcare, Little 
Chalfont, United Kingdom). Densitometry analysis was performed on the obtained 
images using ImageJ (NIH). SDS-PAGE collagen bands were normalized to the no-
cathepsin control groups run in each gel. The cathepsin bands imaged in zymography gels 
and Western blots were normalized to 3.3 pmol of recombinant catK and catL run in each 
gel/blot. 
4.2.6 Statistical Analysis 
 Statistical significance for SDS-PAGE, zymography, and Western blot data were 
determined by a one-way ANOVA in GraphPad Prism between each normalized 
incubation group with each replicate repeated at least three times and statistical 
significance considered when p<0.05. 
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4.3 Results 
4.3.1 Sequential co-incubation of catK and catL cleaved more type I collagen gel 
and pooled tendon ECM than concurrent co-incubation 
To test the hypothesis that priming matrix substrates with catK before the addition 
of catL would yield a greater amount of collagen cleaved compared to matrix co-
incubated with catK and catL, collagen gels were incubated with either catK or catL 
alone, incubated with catK and catL added concurrently, or incubated with sequential 
catK and catL where the matrix substrates were primed with catK for 4 hrs prior to 
adding catL for the remaining 4hrs of the 8hr incubation period. After the incubation 
period, each sample was centrifuged and separated into the soluble (matrix fragment and 
free cathepsins) and pellet (insoluble matrix and bound cathepsins) fractions. Collagen 
cleavage in the pellet fractions and degradation in the soluble fractions was assessed with 
Coomassie stained SDS-PAGE. The amount of collagen cleaved is expressed as percent 
of collagen fragments present in the Coomassie stained polyacrylamide gel quantified 
with densitometry and normalized to collagen gel or tendon ECM in the absence of any 
proteases over the 8hr period.  
Little to no collagen fragments were detected in the soluble fraction for any of the 
four conditions after incubation with the collagen gel. In the remaining collagen pellet 
fraction, α1(I), α2(I), and β-chains (α-chain dimers) were visible in all four conditions 
(Fig 4.2A). After normalizing to the no-cathepsin control, 93% of the collagen chains 
were cleaved in the sequential condition, significantly more than when catK or catL were 
incubated with collagen gels alone (29% and 37% cleaved, respectively) or co-incubated 
with collagen gels concurrently (55% cleaved) (Fig 4.2B).  
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 Type I collagen gels were used initially as collagen is the major component in 
tendons, but to determine if the observations with collagen gels would be replicated on 
tendon matrix, a more complex mixture of ECM proteins, homogenized mouse Achilles 
tendon ECM was incubated with catK and catL in the same manner as the collagen gels. 
SDS-PAGE was used to assess the amount of collagen cleaved and degraded from the 
individual tendon ECM incubation method. Soluble and tendon pellet fractions were 
obtained after 8hr incubations with catK and catL. In the soluble tendon ECM control 
group that was incubated only with assay buffer, pH 6, and no cathepsins, there were 
many soluble tendon ECM fragments were present at multiple molecular sizes (Fig 
4.2C,F), due to the partial solubility of collagen in the pH6 assay buffer [114].  When 
comparing catK alone, catL alone, concurrent co-incubation of catK and catL, and the 
sequential co-incubation of primary catK and subsequent incubation with catL, the 
soluble fraction showed that the soluble collagen remained only when incubated with 
catL alone. Significantly less collagen was measured in the soluble fraction of all other 
conditions when compared to the catL alone incubation (Fig 4.2C,D). The collagen in the 
tendon ECM pellet fraction showed no significant differences in the amount of collagen 
cleaved between any of the conditions, even when comparing concurrent co-incubation of 
catK and catL to the sequential co-incubation (Fig 4.2C,E).   
SDS-PAGE showed that after separating control tendon ECM that had only 
incubated with pH6 assay buffer, the tendon pellet control had similar α- and β-chains 
visible as with the collagen gels. In the soluble tendon control group many soluble tendon 
ECM fragments are present at multiple molecular sizes, due to the partial solubility of 
collagen in the pH6 assay buffer [114]. In the experimental groups SDS-PAGE revealed 
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the most matrix was cleaved from the pellet fraction of tendon ECM primed by catK then 
incubated with catL, with 53% collagen cleavage (Fig 4.2F,H). For the soluble fraction, 
incubation with catK degraded significantly more collagen than in the absence of catK, 
regardless of priming, concurrent, or catK alone. When catL was incubated alone with 




Figure 4.2. Matrix substrate co-incubated with sequential catK and catL yields 
greater collagen cleavage than concurrent catK and catL. Collagen gels and 
tendon ECM were incubated with catK alone, catL alone, and catK co-incubated with 
catL concurrently (+), or sequentially (→) for 8hrs. After centrifugation, SDS-PAGE 
was conducted on the soluble and pellet fractions of each experiment. SDS-PAGE 
showed the alpha chains from the collagen pellet with little to no collagen remaining 
in the soluble fraction after 8hr cathepsin incubations (A). Sequentially co-incubated 
catK and catL (→) cleaved significantly more collagen than catK concurrently co-
incubated with catL (+), or either enzyme alone (B). SDS-PAGE on the soluble and 
pellet fractions of individually incubated and pooled tendon ECM showed the 
fragments released into the soluble fraction, and the remaining alpha chains in the 
pellet after incubation (C,F). In the soluble fraction of the individual and pooled 
tendon incubations, catL alone was not able to degrade the ECM fragments, leaving 
significantly more fragments than catK alone, concurrent (+) and sequential (→) catK 
and catL (C,D,F,G). The pellet fraction of the individual incubations showed no 
differences in the amount of cleaved tendon ECM between groups (C,E). In the pooled 
tendon ECM pellet fraction, similarly to the collagen pellet, SDSPAGE showed 
significantly greater cleavage with sequential co-incubation (→) than catK alone, catL 
alone, or concurrent co-incubation of catK and catL (+) (F,H). n=3, * indicates 
statistical significance, p<0.05 as determined by a one-way ANOVA. 
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4.3.2 Cathepsins remained present and active, and displayed cannibalistic 
behaviors after 8hr incubations with collagen gels 
After observing that catK priming collagen I, followed by catL cleavage, yielded 
significantly higher degradation of type I collagen and tendon ECM from the pellet 
fraction than when they were concurrently co-incubated, we next investigated functional 
dynamics between catK and catL that could cause this difference. Active cathepsins are 
subject to autodigestion, or self-cleavage over time, cathepsin-on-cathepsin hydrolysis, a 
condition we termed cathepsin cannibalism, and other mechanisms that could inactivate 
without cleavage [69]; any of these processes could reduce the amount of active 
cathepsins present in the system, reducing total substrate degradation. We tested the 
hypothesis that catK or catL could be cannibalizing one another in the concurrent co-
incubation condition, reducing matrix degradation compared to when catK was pre-
incubated with the matrix prior to addition of catL. To measure the amount of active 
cathepsins remaining after the matrix substrate incubation period, zymography was 
performed on the soluble and reconstituted collagen pellet fractions. Zymography showed 
active catK remained after the 8hr incubation period in both the pellet and soluble 
fractions (Fig 4.3A), however, there was significantly higher amounts of active catK 
remaining when it was incubated alone, in the absence of catL, not added concurrently or 
sequentially. These data suggest that in the presence of the collagen gel, the catK was 
stabilized, and protected from autodigestion; this was confirmed by Western blot for catK 
protein (Fig 4.3D). There was a significant loss of catK protein when incubated with 
catL, either concurrently or sequentially, suggesting cannibalistic interactions of catL on 
catK, but the loss of catK was significantly reduced in the sequential case compared to 
the concurrent co-incubation condition (Fig 4.3D,E). 
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Zymography also showed a loss in the amount of active catL in the collagen pellet 
fraction when co-incubated with catK either concurrently or sequentially (Fig 4.3A,C). 
This was confirmed by significantly more immunodetectable catL protein when 
incubated alone than when either concurrently or sequentially co-incubated with catK on 
the collagen gels (Fig 4.3F). Together these results suggest bidirectional cathepsin 
cannibalism, with catK hydrolyzing catL and catL hydrolyzing catK. There was more 
catK in the pellet fraction than in the soluble fraction, but the opposite for catL with a 





Figure 4.3. Sequential co-incubation of catK and catL with matrix substrate 
sustained active catK, while bi-directional cannibalism of catK and catL 
occurred with concurrent co-incubation. Zymography and Western blots against 
catK and catL were conducted to measure the amount of active catK and catL 
remaining after incubation with collagen gels and tendon ECM. CatK and catL were 
active (A) after 8hr incubations with collagen as indicated by zymography in the 
soluble and pellet fractions. Significantly more total catK was active when collagen is 
sequentially co-incubated catK and catL (→) than the concurrent co-incubation (+) 
(B). More total catL was active when collagen is primed with catK (→) than the 
concurrent co-incubation with catK (+), due to the reduced incubation time (C). CatK 
Western blot detected no catK in the soluble fraction, but also showed in the pellet 
fraction less total catK when concurrently co-incubated with catL (+), indicating catL 
cannibalism of catK (D,E). By Western, less total catL was present when co-incubated 
with catK, even when sequentially co-incubated with catK (→), suggesting catK may 
also have been cannibalizing catL (D,F). n=3, * indicates statistical significance, 
p<0.05 as determined by a one-way ANOVA. 
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4.3.3 CatK cannibalized catL when co-incubated without substrate 
Active catK was present in both the soluble and pellet fractions after incubating 
with collagen gels for 8hrs, suggesting that the presence of substrate increases the 
stability of proteases in the system, whereas it has been reported that with soluble 
substrates or simple amino acid short peptide substrates, they were inactivated over time 
periods of two hours [69]. To determine if substrate was influencing the dynamics during 
the co-incubation conditions, we next incubated catK and catL alone or together, in the 
absence of substrate. The hypothesis was that, according to enzyme kinetics, in the 
absence of substrate, the cathepsins would bind to and hydrolyze each other more than 
when substrate is present, as though additional substrates were competitive binders for 
the active cathepsins.  When catK was incubated alone, catK autodigestion occurred as 
indicated by the loss of the active catK band over time in the zymogram, even in the 
absence of any other protease (Fig 4.4A,B). This was corroborated by the loss of catK 
protein over time in the immunoblots (Fig 4.4A,D). Some catL autodigestion occurred, 
but not to the same extent as catK (Fig 4.4). When both catK and catL were concurrently 
co-incubated, in the absence of substrate, there was a significant loss of active catL signal 
in the zymogram by 8hrs that was not seen when catL was incubated alone (Fig 4.4C). 
 To test if catL was still lost from the system after its sequential addition, catK was 
incubated alone for 4 hours, then catL was added for the remaining 4 hours to match the 
protocols of the collagen gel experiments from Figure 4.3. Whereas with collagen 
substrate, catK was detected after 8 hours in the soluble fraction after sequential addition 
of catL (Fig 4.3A), in the absence of substrate for this experiment, there was a significant 
loss of detectable active catK by zymography and total catK protein by immunoblot after 
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8hrs (Fig 4.4A, B). For shorter sequential co-incubation periods, with accompanying 
shorter catK pre-incubation periods of 0.5 and 2 hours prior to addition of catL, in the 1 
and 4hr sequential conditions, respectively, a time dependent loss of catK was observed. 
CatL, on the other hand, showed no significant loss, similar to when it was incubated in 
the presence of collagen. 
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Figure 4.4. CatK cannibalized catL when co-incubated without substrate. CatK 
and catL were incubated without substrate for 1, 4, and 8hrs either alone, concurrently 
(+), or sequentially. In the sequential conditions, catL was introduced at the halfway 
point of each time point (0.5, 1, and 4hrs, respectively). Zymography showed active 
catK and catL remaining after incubation (A). CatK and catL are active at 1hr, with 
4hr and 8hr time points showing decreasing signal, indicating auto-digestion (B,C). 
Significantly more catK was active when concurrently co-incubated with catL (+) 
compared to catK alone and sequential co-incubation of catK and catL (→) (B). 
However, active catL significantly decreased over time when co-incubated with catK 
(C). Confirming zymography trends, significantly more catK was detected by Western 
blot when co-incubated with catL compared to catK alone. Furthermore, significantly 
increased catK was detected with longer exposure to catL in the concurrent co-
incubation compared to the sequential co-incubation at all time points (D). Western 
blot also showed catL significantly decreasing over time when co-incubated with 
catK, even after 1hr and even when catL was added sequentially, suggesting catK 
cannibalism of catL (E). n=3, * indicates statistical significance, # indicates statistical 
significance from the corresponding 1hr bar within the same condition, p<0.05 as 
determined by a one-way ANOVA. 
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4.3.4 Similar levels of tendon ECM cleavage were observed between tendon 
primed with catK before incubating with catL and tendon primed with catL before 
incubating with catK 
 Our central hypothesis of this study was that priming of collagen I by catK would 
cleave and expose additional sites susceptible to hydrolysis by catL, but the question 
remained of whether catL could prime for greater cleavage by catK or if subsequent 
addition of fresh protease of the same type to the system would have similar effects on 
matrix degradation as the mixed combination of catK/catL. To test this hypothesis, 
tendon ECM was incubated with the following catK/catL combinations: 1) primed with 
catK, then incubated with catL, 2) primed with catL, then incubated with catK, 3) primed 
with catK, then incubated with fresh catK, and 4) primed with catL, then incubated with 
fresh catL. Each priming/preincubation period was 4hrs, then the subsequent addition of 
the secondary protease for an additional 4 hrs as was done above.  
For the soluble fraction, priming with catL and sequential co-incubation of fresh 
catL only degraded 23% (n=3, p<0.05) of the no protease control, but there was 85% 
degradation when catK was the secondary protease after priming with catL (n=3, 
p<0.05). Conversely, priming with catK, and subsequent incubation with catL led to 89% 
of the collagen being degraded, and 93% was degraded when the secondary protease was 
fresh catK (Fig 4.5A,B). This was significantly higher than either of the catL priming 
conditions (n=3, p<0.05). From the tendon ECM pellet fractions, 71% collagen was 
cleaved when primed with catK and then incubated with catL, significantly higher than 
the 26% cleaved from tendon ECM that was primed with catL, and then subsequently 







Figure 4.5. Tendon ECM primed with catK and then incubated with catL did not 
cleave more than tendon primed with catL and then incubated with catK. Tendon 
ECM degradation and active catK and catL were evaluated after 8hr sequential co-
incubations with either catK or catL as the primary protease. SDS-PAGE showed that 
primary catK results in greater cleavage in the tendon ECM pellet (A,C) and greater 
degradation in the soluble fraction (A,B) than primary catL, though not significantly 
different. n=3, * indicates statistical significance, p<0.05 as determined by a one-way 
ANOVA. 
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4.3.5 CatK cannibalized catL when co-incubated in the presence of tendon ECM 
for 8hrs 
It was hypothesized that catK and catL would be present and active after 
incubating with the tendon ECM substrate for 8hrs. Additionally, it was hypothesized that 
priming tendon ECM with catK would yield more active and total measured catK and 
catL signal than priming ECM with catL. To test these hypotheses, zymography was 
performed to assess for active catK and catL, and Western blots were probed for catK and 
catL to detect total protein amounts. We first confirmed that no resident cathepsins were 
active from the tendon ECM after homogenization by incubating the substrate in either 
pH6 assay buffer only or with exogenously added catK. Active catK signal was observed 






Figure 4.6. CatK retained activity in the presence of homogenized tendon ECM 
after 8hrs of incubation. Zymography shows active catK signal only when 
homogenized tendon ECM was exogenously incubated with catK, indicating no 
residually active cathepsins from the tendon ECM alone.  
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Zymography was performed to assess amounts of active catK and catL under 
these new co-incubation conditions, and Western blots were used to probe for catK and 
catL total protein, together to determine the extent and direction of cathepsin 
cannibalism. From the zymograms, there was little to no active catK and catL detected in 
the zymogram of the soluble fraction, but the amounts of active catK and catL in the 
pellet fractions was similar between each condition. This indicates that most of the active 
cathepsins remaining after the 8hr incubations with tendon ECM were associated with the 
tendon pellet and not free in the soluble fraction (Fig 4.7A).   
Immunoblots probing for catK similarly revealed detectable catK only in the 
tendon pellet fraction after the 8hr incubations. No differences were measured in the total 
amount of catK present between any of the three conditions when catK was incubated 
with catL (Fig 4.7B, data not shown). CatL was detected by Western blot in both the 
soluble and tendon pellet fractions after incubating with tendon ECM for 8hrs. 
Interesting, only under conditions when catK was incubated with catL is there 





Figure 4.7. CatK cannibalized catL when co-incubated in the presence of tendon 
ECM for 8hrs. Zymography revealed limited active cathepsins in the soluble fraction, 
while similar amounts of active catK and catL remained associated with the tendon 
ECM pellet regardless of the priming sequence (A). Western blot for catK detected 
greater signal with tendon ECM primed with catK than tendon primed with catL, 
however, only tendon ECM primed and subsequently incubated with catK was 
significantly different from the other groups (B, data not shown). Western blot for catL 
showed similar levels detected in the pellet fraction, regardless of incubation 
conditions, but significantly less catL present in the soluble fraction when catL was 
co-incubated with catK (C,D). n=3, * indicates statistical significance, p<0.05 as 
determined by a one-way ANOVA. 
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4.3.6 Soluble tendon ECM was degraded into small fragments that stabilize 
cathepsins during time course incubations 
The soluble fraction of tendon ECM was degraded significantly when incubated 
in the presence of catK. Beginning with insoluble ECM (collagen gels or tendon ECM 
pellet), our model assumed that catK and catL hydrolyzed protein in the bulk pellet, 
solubilizing it, and releasing it from the bulk into the supernatant. Any active protease in 
the supernatant could then bind and hydrolyze the released fragments or bind and 
hydrolyze more ECM protein in the bulk pellet. These solubilized protein substrates 
could distract the active cathepsins from further cleavage of the bulk pellet, while also 
stabilizing the active cathepsins in the soluble fraction that would now have substrate 
protein, which was demonstrated earlier to sustain the active cathepsins.  
To test if the solubilized tendon fragments could stabilize the active catK and 
catL, extending their active time in the absence of bulk pellet ECM, and if cathepsin 
cannibalistic interactions during co-incubations or sequential incubations altered their 
levels, tendon ECM was incubated in assay buffer with no protease for 8hrs to collect 
non-enzymatically released soluble ECM fragments (soluble control, Fig 4.2C). These 
solubilized tendon ECM fragments were then concurrently co-incubated with catK and 
catL, primed with catK and then sequential incubation with catL, or primed with catL and 
then subsequent incubation with catK. The reactions were stopped at different time points 
to assess the loss of active enzyme and substrate over time: 1) at 4hr time point before 
addition of the secondary protease, 2) at the 6hr point, 2hrs of secondary protease co-
incubation, and 3) at 8hr time point, 4hrs of secondary protease co-incubation. Control 
samples of soluble tendon ECM fragments were incubated for 4, 6, and 8hrs in the 
absence of any proteases.  
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Soluble tendon ECM fragments were degraded below the detection limits of the 
Coomassie stain by 4 hours when either primed with catK or when concurrently co-
incubated with catK. Priming with catL did not degrade these fragments by 4 hours, but 
when sequentially incubated with catK, there was degradation during those 2 and 4 hours, 
but by the end of those incubation periods of 6 and 8hrs, respectively, soluble tendon 
ECM fragments were still visible (Fig 4.8A). Although no ECM fragments were detected 
in the stained polyacrylamide gel, their presence as a substrate were still sufficient to 
stabilize active catK and catL for the 6 and 8hr periods as shown by the zymography (Fig 
4.8B) and by Western blots (Fig 4.8C), regardless of the co- or pre-incubation condition. 
Additionally, by zymography, active cathepsin bands are present around 250 kD, 
indicating active cathepsins were binding to larger ECM fragments as well as smaller 






Figure 4.8. Co-incubation time course with soluble tendon ECM showed 
stabilization of catK and catL with greatest degradation when catK was initially 
present. Concurrent and sequential catK and catL were incubated with soluble tendon 
ECM for 4, 6, and 8hrs. SDS-PAGE showed the soluble tendon ECM remaining after 
incubation time course. At all time points with either the concurrent co-incubation or 
when soluble tendon ECM was primed with catK before the addition of catL, the ECM 
fragments were below Coomassie detection. Soluble tendon ECM primed with catL 
was degraded only after catK was added, with fragments still visible even by 8hrs (A). 
Soluble tendon ECM sustained active catK and catL by zymography at all 3 time 
points. CatK was active and associated with tendon ECM fragments at multiple 
molecular sizes throughout the zymography gel (B). Similarly, by Western blot catK 




This study demonstrated that priming collagen matrix substrates with catK and 
then incubating with catL resulted in greater cleavage than when the substrates were 
concurrently co-incubated with catK and catL (Fig 4.2). Lower catK and catL signal was 
measured by zymography and Western with concurrent co-incubation of catK and catL 
with collagen gels when compared to the sequential co-incubation (Fig 4.3). This 
suggested that the limited matrix cleaved in the concurrent co-incubation condition could 
be due to cathepsin cannibalism. In the catK and catL incubations without substrate, we 
demonstrated that catK cannibalized catL, suggesting the presence of substrate impacts 
the hydrolytic behavior of catK (Fig 4.4). After identifying increased cleavage of tendon 
ECM when primed with catK and then incubated with catL, sequential groups were 
compared varying the cathepsin that primed the tendon ECM. It was found that when 
catK was co-incubated with catL, regardless of sequence, catK cannibalized catL. 
However, the sequential co-incubations of catK and catL did not differ in the amount of 
cleaved tendon ECM (Fig 4.5, 4.7). These data suggested that differences in tendon 
matrix cleavage happened at an earlier point during the incubation time course. 
Interestingly, soluble tendon ECM incubated with concurrent and sequential catK then 
catL degraded tendon fragments before sequential catL then catK. These fragments, even 
though below Coomassie detection limits still stabilized catK and catL by zymography 
and Western blot (Fig 4.8). 
In order to understand how cathepsins cooperatively facilitate early tendon injury, 
the biochemical mechanisms that facilitate degeneration of tendon macromolecular 
structure need to be identified. Many studies have revealed how individual proteases are 
able to degrade extracellular matrix substrates [25,42,115–118]. However, it is known 
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that cathepsins are part of a complex proteolytic network with interacting species that 
enhance and inhibit proteolytic potential of multiple families [58,68,69]. Given the 
temporal upregulation of catK and catL in the previously rat rotator cuff tendon injury 
model [5], the objective of this study was to investigate how concurrent and sequential 
co-incubations of catK and catL act in concert to degrade a type I collagen-rich substrate. 
The hypothesis was that sequential catK then catL would result in greater substrate 
degradation than concurrent catK and catL. Specifically, we tested the hypothesis that 
catK, as the most potent mammalian collagenase, initiated collagen degradation by 
cleaving at multiple sites, exposes sites further susceptible for catL to continue cleavage.  
 Our finding of increased cleavage of matrix substrate from the pellet fraction of 
collagen gels and pooled tendon ECM when primed with catK and then incubated with 
catL suggest that introducing proteases to a substrate in sequence results in more 
efficacious matrix degradation. Priming matrix with catK allows cleavage of the matrix 
substrates, generating soluble fragments and freeing other cleavage sites, allowing for 
continued cleavage with the addition of catL. In an in vivo tendon context, the cleavage 
of the pellet fraction most closely reflects the potential degradation of tendon ECM in the 
presence of cathepsins. However, we found that when fragments were cleaved and 
released into the soluble fraction, even after further degradation, these fragments were 
able to stabilize active cathepsins for much longer than if the proteases were without 
substrate. This suggests that in the local tendon microenvironment, after insoluble matrix 
is cleaved, if not cleared away in synovial fluid, degraded fragments may be able to 
sustain active cathepsins for prolonged cleavage and degeneration, even if only small 
concentrations of cathepsins are present.  
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After incubating collagen gels with catK and catL for 8hrs, zymography and 
Western blot data suggested catK and catL may be cannibalizing each other when 
concurrently co-incubated with the collagen gels, distracting from degradation of the 
substrate. We have previously reported the propensity for cathepsin S to cannibalize catK 
even in the presence of an collagen substrate [69]. This is the first time we have 
demonstrated bi-directional cannibalism between catK and catL in the presence of a 
collagen substrate.  Given that catK and catL were present and active after 8hr co-
incubations with a collagen substrate, in addition to the cannibalistic behaviors observed 
between the two, we evaluated the effect of cathepsin co-incubation over time without 
substrate. From the observed results with the collagen substrate, the hypothesis was that 
the stability of catK and catL, and the dynamic interactions between the two would 
change over time. The amount of catK detected by zymography and western decreased by 
8 hrs, due to autodigestion (Fig 4.4), unlike when in the presence of collagen. Contrary to 
the zymography results from the collagen gel incubations, more catK was detected by 
zymography and Western blot when co-incubated with catL than when incubated alone 
(Fig 4.4B,D). Unlike catK, catL was particularly stable over time when incubated alone. 
However, less catL was immunodetectable over time when co-incubated with catK (Fig 
4.4E), all suggesting that without substrate catK cannibalizes catL and this cannibalistic 
action protects catK from autodigestion observed when catK is incubated alone. These 
data point to a single direction of cannibalism when no substrate is present. However, 
when in the presence of collagen, catK and catL display bi-directional cannibalism, 
suggesting that the substrate does dictate some of the proteolytic dynamics, yielding 
substrate-dependent responses.  
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We compared multiple sequential incubation conditions to test the hypothesis that 
tendon ECM primed with catK and then incubated with catL degrades more ECM than 
when tendon was primed with catL and then incubated with catK.  Most of the fragment 
cleavage and degradation occurred in the sequential co-incubations primed with catK, 
though the quantification did not show significant differences. The presence of multiple 
types of macromolecules in the tendon ECM besides collagen, such as elastin and 
proteoglycans, could have contributed to the confounding quantifications [40–42,119]. 
The comparison between the sequential conditions yielded more subtle differences and 
could be a result of the complex interactions between the cathepsins and the varying 
components of the tendon ECM milieu. Studies have published on the modifications in 
cathepsin activity by glycosaminoglycans, particularly in acidic conditions [25,35,73]. 
CatL Western blot revealed no significant differences between concurrent and sequential 
co-incubations of catK and catL, but catL—both alone and sequentially as primary and 
secondary cathepsins—was different from all other groups. Similarly to the collagen gel 
incubations, these results suggest cannibalism of catL by catK with co-incubation, even 
when catL is the primary cathepsin and has an opportunity to bind to matrix substrate.  
To differentiate between the amount of soluble tendon ECM degraded and active 
catK and catL over time between concurrently and sequentially co-incubated with catK 
and catL, we conducted a time course experiment, incubating each group and stopping 
the incubations after 4, 6, or 8hrs.  Though it appeared by SDS-PAGE that fragments 
were fully degraded in the concurrent incubation and when soluble tendon ECM was 
primed with catK, active catK and catL were both present at all three time points in all 
three co-incubation conditions where added. Additionally, catK appeared active 
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continuously through the zymography gel suggesting that catK was associated with 
fragments at many different molecular sizes. In the 4hr sequential condition with catL, 
where catK was not added, this pattern is not observed, suggesting catL did not associate 
with these fragments. We and others have published that cathepsins are active by 
zymography while still associated with substrate [5,80,102,120,121]. This result 
contrasted with the zymography results from the direct incubations with the tendon ECM, 
where very little active catK and catL were observed in the soluble fraction. This 
difference in cathepsin behavior may suggest that catK and catL have a higher affinity for 
larger tendon ECM macromolecules, but will still bind to and hydrolyze smaller, more 
soluble fragments. Furthermore, studies have shown that certain GAGs, in addition to 
serving as a substrate for cathepsins, enhance cathepsin K activity [14,25,34]. Particularly 
as there were no larger insoluble macromolecules to bind to in the time course 
experiment, the soluble substrate incubations served as substrate for binding and 
stabilizing active catK and catL over the 8hr time course. Overall, this data set suggests 
that catK and catL may prefer larger insoluble tendon matrix macromolecules, but that 
even the presence of soluble tendon ECM fragments stabilizes active catK and catL and 
serves as a reservoir for extended hydrolysis.  
The findings of this study have many implications for understanding how 
cathepsins contribute to the progression of tissue destructive diseases characterized by 
matrix degradation. Intra-and interfamilial proteolytic crosstalk, not just the actions of a 
single protease, may be driving degeneration [5,80,108]. These data provide motivation 
to study cellular mechanisms of proteolytic upregulation. Specifically in tendon disease, 
cathepsins K and L [5,80], MMP-1, -2, and -13, and their endogenous inhibitors, are 
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dysregulated in rat and human tendinopathy [1,3,63,79]. Further studies on the interactive 
effects of cathepsins and MMPs on tendon degeneration are necessary to determine an 
appropriate strategy for preventing disease progression. Cathepsins are very tightly 
regulated proteases for deliberate substrate degradation, but can display substrate 
promiscuity [11,13,14,16]. The stabilization of active catK by the presence of either a 
collagen substrate or catL, in a way that is not observed when incubated alone, suggests 
that even brief upregulation of secreted and active catK in a tendon injury context can 
result in substantial matrix degeneration.   
Although difficult to identify in vivo, the findings here on cannibalistic behaviors 
of catK and catL, particularly in the presence of a collagen substrate, point to potential 
regulatory efforts by tenocytes to restrict potent collagenases from excessive matrix 
hydrolysis. This could imply that only one of a series of upregulated cathepsins would be 
the ideal target of inhibition. Alternatively, it could imply that inhibiting only one 
protease at one time, or even one family of proteases, may be insufficient to arrest the 
progression of disease. Cannibalism may also prove a useful strategy for localized 
cathepsin inhibition. Currently all available cathepsin inhibitors have failed phase II and 
III clinical trials due to unintended side effects [9,122,123]. We also have shown that 
direct cathepsin inhibition may inhibit certain cathepsins, but result in counterintuitive 
upregulation of others [70]. Because we know the proteolytic network is connected [58], 
introduction of inhibitors specific to cathepsins and/or MMPs may have unintended 
consequences for tendon tissue homeostasis, and thus this impact will have to be 
elucidated. 
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This study presented with several limitations. Mouse catL was used in the 
incubation experiments because catK and catL were found upregulated in our published 
model of early stage rotator cuff injury in rats. However, the murine catL ortholog, 
human cathepsin V, would provide more clinical relevance in future translational studies 
investigating cathepsin-mediated tendon matrix degeneration. Furthermore, human catK 
was also used in these studies because there is no commercially available murine catK. 
Although the catK between these two species display pointed differences in response to 
certain inhibitors [77], catK is also the only cathepsin unambiguously implicated in the 
bone resorption in both humans and mice—a process dominated by the degradation of 
type I collagen [22]. This study used homogenized tendon ECM as a test bed for 
degradation and active enzyme levels in co-incubations. This system does not completely 
recapitulate proteolytic actions on fully organized tendon, but helped to eliminate any 
confounding proteolytic impact from intracellular proteases present in resident tenocytes. 
In summary, we have demonstrated increased hydrolysis of collagen-based matrix 
substrate with sequential co-incubation of catK and catL when compared to concurrent 
co-incubation of catK and catL, with evidence of enzyme stabilization even through 8hrs. 
This study has also revealed substrate dependent cannibalistic behaviors between catK 
and catL with implications for the progression of tendon degeneration. We also showed 
that even though priming tendon ECM with catK and then incubating with catL did not 
hydrolyze more substrate than then inverse by the end of 8hrs, priming with catK resulted 
in hydrolysis of soluble tendon ECM fragment below Coomassie detection earlier than 
priming with catL. The varied hydrolytic and cannibalistic interactions between catK and 
catL when in the presence of a collagen matrix substrate point to the complexities of the 
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proteolytic network at play in tissue degradation. This study will help to inform potential 
strategies for proteolytic inhibition to prevent progression of tendon disease and other 
pathologies characterized by collagen matrix degeneration. 
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS  
5.1 Major Findings 
 The objective of this dissertation research was to investigate the cooperative role 
of cathepsins and MMPs in the progression of tendon ECM damage. Previous work has 
identified cathepsins as major players in rat rotator cuff tendon overuse, osteoporosis and 
osteoarthritic synovium [5,9,11,59] and shown MMPs upregulated in early stage rat 
tendon injury [79]. However, collagenolytic enzymes and their endogenous inhibitors are 
part of a complex proteolytic network with connected and interactive effects on matrix 
protein hydrolysis. In our previously published data on a rat model of rotator cuff injury, 
we identified a temporal upregulation of cathepsins K and L in supraspinatus tendon 
tissue at 4 and 8 weeks of injury, revealing a time-dependent regulatory mechanism 
leading to tissue damage. To fully characterize this model of injury our studies here 
extended the time course of injury to 2 and 10 weeks to identify the point of peak 
upregulation of cathepsins and MMPs. We found evidence of injury in the supraspinatus 
tendon insertion and degenerative changes in the nearby articular cartilage [80]. 
However, we observed no upregulation of cathepsins or MMPs at 2 or 10 weeks of 
injury, suggesting the peak proteolytic upregulation occurred between these two time 
points. This work revealed the importance of identifying appropriate targets and key 
points for optimal intervention strategies to prevent the progression of degenerative 
tendon disorders.  
  In order to further investigate the cooperative effects of cathepsins on tendon 
matrix degradation, we developed a collagen gel incubation model and a tendon ECM 
incubation model. The objective of this study was to identify the protease incubation 
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sequence that would result in the most matrix substrate degradation. We discovered that 
in both collagen matrix and type I collagen-rich tendon ECM, initial incubation with 
cathepsin K primed the matrix for subsequent degradation by cathepsin L. Additionally, 
we found that soluble and insoluble collagen-rich ECM is able to stabilize active 
cathepsins K and L and extend proteolysis beyond the expected lifetime of the proteases 
when not in the presence of substrate. Furthermore, we present evidence that cathepsins 
K and L exhibit specific distraction and cannibalistic behaviors without substrate and in 
the presence of a collagen-rich substrate that impact the protease-substrate dynamics such 
that less matrix degradation occurs. These findings provide key insight into potential 
consequences of cathepsin behaviors in vivo: 1) Prolonged active cathepsins highlight the 
destructive potential of these proteases even in tissues where only a slight upregulation of 
an active protease, particularly cathepsin K, occurs. 2) These findings suggest that 
cannibalism may be a regulatory mechanism to control cathepsin activity extracellularly. 
3) This data demonstrates that each of the species in the proteolytic network can impact 
the other nodes in a way that modulates EC degradation. 
 Taken together, the work in this dissertation begins to identify some of the 
complex underlying proteolytic mechanisms that contribute to the degeneration of tendon 
matrix and surrounding tissues. Furthermore, this work has implications for 
understanding the degradation of collagen-rich substrates in various pathological 
contexts. We have identified unique substrate-specific and substrate-independent 
behaviors of cysteine cathepsins that will be crucial for development of future studies and 
understanding the functional roles of cathepsins in the greater context of the proteolytic 
network. The hope is that with the information gathered through this research we are able 
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to make strides towards developing appropriate and efficacious interventional strategies 
to prevent tissue degeneration and exploiting robust biological machinery to tune 
properties of extracellular matrix components in vivo and in vitro for tissue engineering 
and enzymology research efforts. 
5.2 Limitations and Future Considerations  
  This work also highlights the need for clinically translational studies to identify 
appropriate targets and time points of intervention in humans. Because the rat is a 
quadruped animal, our rat model of rotator cuff injury cannot fully recapitulate human 
pathology [50]. Still, the data gathered on the behaviors of cathepsin K and cathepsin L 
may prove crucial to future translational studies and inhibitory strategies. Cathepsin L 
was upregulated for the longest period of time in our model of rotator cuff injury. 
However, cathepsin K is a more powerful collagenase. This suggests that both proteases 
could be viable targets for intervention. Because of how they are temporally regulated, it 
may be necessary to employ multiple inhibitors at multiple points for maximum efficacy 
to deter disease progression.  
 Furthermore, this injury model does not translationally represent the common 
points of intervention in humans. Typically patients with chronic non-inflammatory 
tendon injuries have progressed further into the degenerative spectrum before receiving 
medical intervention than the animals in this research [44,50,51]. This also speaks to the 
need to develop models to elucidate underlying mechanisms of more acute, inflammatory 
tendon injuries. Some studies have used rodent models of end stage tendinopathy or full 
thickness tears and denervation [86], and other studies have analyzed the expression of 
markers in human torn rotator cuff tendon [5,124], but no animals models have been able 
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to fully recapitulate early stage inflammatory tendon injury. It is also imperative to find 
ways to evaluate levels of active proteases in humans that could inform appropriate 
inhibition strategies. Because we identified that nearby supraspinatus tendon and articular 
cartilage that share synovial fluid both displayed evidence of damage after injury to the 
rotator cuff, sampling the level of active enzymes in the synovium may be a promising 
minimally invasive metric for determining course of action. Identifying evidence of 
damage to multiple nearby tissues that share synovial fluids highlight the need for 
additional studies to identify potential pathological changes consistent with full cuff 
arthropathy [95] to prevent degeneration of multiple tissues in addition to the tendon 
ECM, such as articular cartilage and rotator cuff muscles [52].  
 The data in both aims of this dissertation research use rodent models to assess for 
the amount of active proteases, and thus we focus on the activity of mouse cathepsin L. 
However, although highly homologous with human cathepsin L, mouse cathepsin is 
orthologous with human cathepsin V. It has been found that cathepsin V is the most 
potent mammalian elastase, in addition to displaying some collagenolytic activity 
[8,15,23]. Further studies are needed to determine if human cathepsin V exhibits the same 
behaviors—degrading collagen-rich matrix and cannibalistically interacting with catK—
as mouse cathepsin L.  
 Studies have also identified MMP (1, 2, 8, 9, 13, and 14) as potent mammalian 
collagenases and contribute to the progression of tendinopathy [3,4,21,79]. However, we 
did not observe upregulation of MMP-2 or MMP-9 at the 2 week or 10 week points of 
our rat model of tendinopathy [80]. Though we did not capture any upregulation at these 
time points, this does not mean that MMPs did not contribute to degradation. Further 
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studies are needed to understand how collagenolytic MMPs contribute to or impede 
tendon matrix degradation and interact with cathepsins upregulated in this system. 
Specifically studies are needed to determine how they may enhance, be activated by [68], 
cannibalize, or serve as a substrate for active cathepsins. MMPs incorporated into the co-
incubation experiments with cathepsins and collagen gel matrix or tendon ECM would 
provide insight into how these families interact in the presence of collagen-rich substrate. 
Given that catK can activate MMP-9 [68], concurrently incubating MMPs with 
cathepsins may result in increased cleavage of collagen matrix substrate when compared 
to matrix that had been pre-incubated with either protease before incubating with the 
other. These incubations could also answer questions about the impacts of acidic versus 
neutral microenvironments on the activity of cathepsins and MMPs. MMPs are known to 
be active at a more neutral pH [7,125], however it has also been hypothesized that local 
acidification of pericellular space may allow extracellular activity of cathepsins [14].  
 In all the recombinant cathepsin co-incubations with collagen matrix substrates in 
Chapter 4, an equimolar amount of each protease was introduced to each reaction. We 
observed substrate-dependent cannibalistic interactions between cathepsin K and mouse 
cathepsin L. However, we did not vary the ratio of catK to catL to determine if this 
impacted the cannibalism dynamics. Because we observed bi-directional cannibalism, by 
altering the ratio of each protease, one cannibalistic direction may dominate. Varied 
ratios of catK and catL may also change the patterns of matrix degradation between the 
concurrent and sequentially incubated groups if an overabundance of one protease 
prevents binding of the other to the substrate, leaving the unbound protease free to 
cannibalize or autodigest. 
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 In a tendon injury context, there may not be equimolar amounts of cathepsins or 
MMPs exposed to the extracellular matrix at a given time. Furthermore, considering that 
cells are able to continually secrete active proteases, quantifying the amount of active 
proteases present in early stage tendon injury will also allow for more tunable inhibition 
strategies. Using zymography, the amount of active cathepsins or MMPs present over a 
time course of injury in an animal model of tendon injury can be quantified by 
normalizing densitometric quantification values of band intensities to that of a standard 
curve with linearly increasing amount run on the same gel. Depending on the targeted 
proteases and the kinetics of each specific inhibitor, the concentration of inhibitor could 
then be matched to the protease concentration at the decided point of intervention.  These 
data would be key to determining which inhibition strategy is best, the point of most 
effective inhibition, and how much inhibitor is necessary to target collagenolytic activity. 
If developed for translational human studies this could even provide ways of assessing 
the amount of specific inhibitors needed to prevent collagenolytic activity, even with 
patient to patient variability. 
 In addition to incorporating MMPs into the incubation studies with tendon matrix, 
it may be important to also introduce cathepsin and MMP inhibitors to the incubation 
reactions as well, to understand how this may interfere with proteolytic degradation of 
matrix substrate. In an in vitro system, it may prove to be difficult to ensure targeted 
inhibition of only one protease; quantifying the amount of active proteases could be 
confounding if the inhibitor concentration is too high, impacting the addition of any 
secondary protease—particularly if the secondary protease is in the same family. 
Alternatively, if the inhibitor concentration is too low, the primary protease may not be 
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fully inhibited and still be available to catalytically interact with the substrate or 
cannibalistically interact with the secondary protease. Beyond recombinant protein 
experiments, investigating the effects of cathepsin or MMP inhibition on measured 
amounts of active proteases and tissue degradation in a tendon injury context will 
determine if there are any counterintuitive cellular responses as a result of inhibition. We 
know that cathepsins can respond differently to the same inhibitor, and cellular responses 
to inhibition could be dependent on inhibitor type or inhibitor concentration. These data 
would be important for successful future animal model or translational studies. 
 The findings in this dissertation research and the potential future directions 
highlight an opportunity to use computational modeling as a tool to identify likely 
interactions of multiple proteases within and between families, and even interactions with 
their respective inhibitors. Computational tools would provide the ability to predict 
preferential binding of multiple enzymes and/or inhibitors in the presence of complex and 
heterogeneous substrates. Instead of experimentally having to determine likely 
interactions between every species that can drive tendon degradation, we can train 
models on behaviors of cathepsins, MMPs, and inhibitors on tendon matrix based on data 
collected in this study and future preliminary work. Data from these studies can identify 
the most likely interactions and inform experimental approaches to protect tendon matrix 




APPENDIX A: INVESTIGATING THE NECESSITY OF CATHEPSIN 
K FOR TENDON MATRIX DEGRADATION USING A CATK-/- 
MOUSE MODEL 
A.1. Introduction 
 Cathepsin K is the most potent mammalian collagenase and plays a large role in 
tissue remodeling [6,9,11,16,126]. First identified in osteoclasts[6,11,12,16,18], catK is 
considered to be the primary protease responsible for bone resorption in humans and 
mice [18,21,22]. Pycnodysostosis is a rare inherited disease that results in a mutation in 
the catK gene leading to osteopetrotic, dense and brittle bone. People with catK 
deficiency (catK-/-) have dysfunctional osteoclasts that are unable to degrade bone matrix 
and display overall diminished capacities for tissue remodeling. [6,74] Studies have also 
found an accumulation of collagen in cellular compartments of fibroblasts from people 
with pycnodysostosis [75]. A  catK-/- mouse model was developed in order to investigate 
the impact of cathepsin K deficiency on tissue remodeling and potentially develop 
strategies for preventing osteoporosis [6,74,77].  
 Due to the reduced capacity for collagen degradation in the catK-/- mouse, this 
model became advantageous for investigating the necessity of catK for the degradation of 
tendon matrix.   We have shown that tendon primed with catK and then incubated with 
catL resulted in greater matrix cleavage than concurrent incubations with catK and catL 
or either protease alone (Fig 4.2). Therefore, we hypothesized that collagen from mice 
deficient in catK would be less susceptible to cleavage by catL compared to wild type 
tendons because the deficient tissues would have never been exposed to catK in normal 
tendon development. We also hypothesized that pre-incubating tendons from catK 
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deficient and wild type mice, and then incubating with catL would result in similar 
cleavage observed between the two genotypes.  
A.2. Methods 
A.2.1. Isolation and homogenization of wild type and cathepsin K deficient mouse 
Achilles tendons 
 All animal procedures were approved by the Georgia Institute of Technology 
Institutional Animal Care and Use Committee. Wild type C57BL/6J mice and mice 
deficient in cathepsin K were obtained from Jackson Laboratory (Bar Harbor, ME) and 
raised to 2-4 months of age before being sacrificed. The left and right Achilles tendons 
were extracted from 12 catK-/- mice and 12 wild type mice as described in section 4.2.2 
and frozen at -20°C until needed for homogenization.  
 Achilles tendons were homogenized in zymography lysis buffer with 0.1mM 
leupeptin in tissue grinding microcentrifuge tubes with resin (Sigma-Aldrich, St. Louis, 
MO) and then centrifuged to remove the soluble tendon tissue lysate. One tendon was 
allocated for each replicate of each condition (n=3/condition) as was described with the 
individual incubation condition in section 4.2.2. The remaining insoluble tendon ECM 
was washed in pH6 assay buffer, then centrifuged, and the buffer was discarded in 
preparation for incubations. 
A.2.2. Cathepsin incubations with tendon ECM 
 Tendon ECM from both wild type and catK-/-  mice were incubated with either 
catL alone or was primed with catK and then subsequently incubated with catL. 
Cathepsin were incubated at 0.2µM concentrations in pH6 assay buffer with the tendon 
ECM. All incubations were conducted at 37°C with slight agitation for 8 hrs total. After 
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the 8hr incubation period, to stop the reaction leupeptin was added to a final 
concentration of 0.1mM. Samples were centrifuged at 25°C for 15 min and then stored at 
-20°C until prepped for SDS-PAGE analysis. 
A.2.3. SDS-PAGE  
 In preparation for electrophoresis, each soluble fraction and remaining pellet 
fraction were prepared with 5X reducing loading dye for SDS-PAGE. 17µL of each 
sample were loaded into 12.5% polyacrylamide gels and separated by molecular weight. 
After separation, the polyacrylamide gels were stained with Coomassie Blue and 
destained, revealing bands indicative of type I collagen α1 and α2 chains, and β-chains, in 
addition to ECM fragments at various molecular sized throughout the gel. 
A.2.4. Statistical Analysis 
 Statistical significance of densitometric values was determined by a three-way 
ANOVA in GraphPad Prism between each incubation condition after normalizing to the 
mean value of the released soluble fragments from the wild type tendon ECM incubated 
with catL only. Each replicate was repeated at least three times and statistical significance 
considered when p<0.05. 
A.3. Results 
A.3.1. Varied cleavage and degradation patterns observed between wild type and 
catK deficient tissues after tendon ECM incubated with catL alone or was 
primed with catL and then incubated with catL. 
 To test the hypotheses that incubating catK-/- tendon ECM with catL alone would 
result in lesser evidence of degradation than wild type tendon ECM, SDS-PAGE was 
 90 
conducted on samples from both incubation conditions. We observed significantly fewer 
collagen fragments in the soluble fraction of catK-/- tendon ECM incubated with catL 
only when normalized to wild type soluble fragments. However, no differences were 
observed between tissues of each genotype in the tendon pellet fraction when ECM was 
incubated with catL alone (Fig A.1).  
 To test the hypothesis that priming catK-/- tendon ECM with catK and then 
incubating with catL would result in similar amount of cleaved and degraded tendon 
matrix between catK-/- and wild type tissues, SDS-PAGE was conducted on these 
samples after the incubation period. No significance was observed between the amount of 
tendon ECM cleaved in the pellet fraction or degraded in the soluble fraction between the 
two tissue genotypes, showing that catK and catL were able to hydrolyze substrate from 
both tissue types. However, much variability was observed between each replicate in all 
conditions in the pellet fraction and when matrix was incubated first with catK and then 









Figure A.1. Varied cleavage and degradation patterns observed between wild 
type (WT) and catK deficient tissues after tendon ECM incubated with catL 
alone or was primed with catL and then incubated with catL. CatL alone does 
not fully degrade soluble tendon ECM fragments, however, significantly fewer 
fragments were observed with catL incubated with catK-/- tendon ECM than wild 
type tendon ECM. When primed with catK and then incubated with catL 
significantly more soluble tendon fragments were degraded in both tissue 
genotypes than when incubated with catL alone. No differences were measured in 
the cleaved collagen in the tendon pellet between wild type and catK-/- tissues in 
either incubation condition.  
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A.4. Discussion 
 The objective of this study was to test if exposure to catK in vivo was impacted 
the proteolytic degradation of tendon using tendon ECM from a cathepsin K deficient 
mouse model. We hypothesized that because catK-/- tendons had never been exposed to 
catK in tendon development, catL would show diminished degradation capacity when 
incubated with catK deficient tendon matrix for 8hrs. We also hypothesized that by 
reintroducing catK in a sequential co-incubation with catL where matrix was first 
incubated with catK and then incubated with catL, this would result in similar levels of 
degradation between catK-/- tendon ECM and wild type tendon ECM.  
 We did observe that, in tissue from mice with either genotype, catL alone was not 
able to fully degrade soluble tendon fragments, and that significantly more fragments 
were degraded when ECM was primed catK before incubating with catL. However, the 
variability between the replicates in the pellet fraction of both incubation conditions and 
the soluble fraction of the sequential incubation condition made it difficult to draw 
conclusions from the data. These tendon incubation experiments were conducted using 
the individual method detailed in section 4.2.2. There, we also observed variability 
between conditions, leading us to hypothesize that pooling the tendon matrix before 
incubating with cathepsins would reduce variability. Given the results of this study, it is 
hypothesized that pooling the tendon ECM before incubating with cathepsins would 
reduce the confounding variability observed. For that reason, it is recommended to use 
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